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ABSTRACT 
Microwave ablation (MWA) is a minimally-invasive modality that is playing 
an increasingly vital role in the treatment of cancer and benign disease. These 
procedures involve the use of a microwave antenna (or an array of antennas) to deliver 
energy to raise tissue temperature above a thermal threshold to induce irreversible cell 
damage. Commonly used clinical MWA systems operate at frequencies of 2450 MHz 
and 915 MHz  . Image-guided percutaneous MWA treatments can be guided by 
intraoperative ultrasound or computed tomography (CT) fluoroscopy, which allows 
the physician to deliver treatments precisely. As such, image-guided  MWA has 
received substantial attention for the treatment of cancer in the past decade that is 
performed in combination with other therapies (radiation therapy) or used as an 
alternative to other more invasive procedures (surgical resection). There has been 
increasing interest in improving the efficacy and specificity of MWA through 
improving energy delivery and application techniques in this domain. This review 
outlines clinical percutaneous MWA technology detailing concepts related to thermal 
dosimetry, the physics of microwave heating, modeling of MWA in tissue, and future 
goals of treatment planning in the context of image-guided MWA procedures.  
Microwave ablation (MWA) treatment is an important alternative to surgical 
resection of tumor in cancer treatment; however, the naive planning tools currently 
available are of limited practical use in real clinical decision making. These geometric 
planning guidelines are insufficient treatment planning tools for accounting for the 
level of unpredicted treatment variability seen during MWA procedures.  
Unanticipated treatment variability may potentially be a cause of cancer recurrence, 
  
and it is difficult to measure treatment variability during MWA procedures on patients. 
Biothermal models have been employed to simulate these types of procedures and aid 
in quantifying the level of treatment variability seen in the clinically. In general, there 
are too many variables to measure and include for a patient-specific physically-based 
simulation. A physically based simulation that accounts for tissue heterogeneities, 
perfusion, and temperature dependent effects will provide improved predictive 
accuracy over existing geometric models. Nevertheless, it is still unclear as to which 
parameters are important, and it we cannot measure their effect on real patients.  A 
potential solution to this problem would be to create a validated physically based 
model to simulate and explore the effect of a range of different patient specific 
variables so that we can focus on the most important ones. This will be a critical 
component in developing MWA planning and guidance tools for accurate and precise 
treatment delivery.  
Image-guided MWA has emerged as a promising modality for tissue ablation. 
Currently, available systems in clinical use operate at 915 MHz or 2.45 GHz. Model-
based predictive planning tools are under investigation for guiding clinical delivery of 
ablation treatments. Currently, most MWA modeling approaches have been focused 
on ablation systems operating at 2.45 GHz. Improving our understanding of the 
dynamics of 915 MHz MWA ablation will lead to better MWA prediction models of 
treatments at this frequency. As progress towards this, the finite element method was 
used to simulate MWA procedures in liver with a clinical 915 MHz ablation 
applicator. A coupled electromagnetic-thermal solver incorporating temperature 
dependent tissue biophysical properties of liver was implemented. Model-based 
  
predictions of transient temperature profiles and ablation zone dimensions were 
compared against experiments in ex vivo bovine liver tissue. Broadband dielectric 
properties of tissue within different regions of the ablation zone were measured and 
reported at 915 MHz and 2.45 GHz. The resultant simulated transverse diameter and 
axial lengths of the ablation zone were in good agreement with ex vivo measurements 
at 30 W (1.0 mm and 1.0 mm) and 60 W (within 0.5 mm and 2.5 mm). Experimentally 
measured radial temperature profiles were within 2-8 °C of the simulated profiles.  
These results will aid in the development of a computational modeling framework for 
predictive planning of ablation procedures.  
While computational models can afford the flexibility for including detailed 
tissue anatomy and heterogeneity, a balance between model complexity, accuracy, and 
required computational resources must be struck for practical clinical application. 
Investigating the contributing factors to ablation variance is therefore important 
because they provide guidelines for the level of detail needed for patient-specific 
modeling of microwave ablation procedures. To that end through simulation the 
impact of 1) heterogeneity of biophysical parameters in tumor vs. healthy tissue, 2) 
applicator placement relative to the tumor, and 3) proximity to large blood vessels on 
microwave ablation (MWA) treatment effect area. This will help identify the 
biophysical properties that have the greatest impact on improving clinical modeling of 
MWA procedures. Our approach was to develop two-compartment models with 
variable tissue properties and simulate MWA procedures performed in liver with 
Perseon Medical’s 915 MHz ST applicator. Input parameters for the dielectric and 
thermal properties considered in this study were based on measurements for healthy 
  
and malignant (primary or metastatic) liver tissue previously reported in the literature. 
Compartment 1 (C1) represented normal, fatty, or cirrhotic liver, and compartment 2 
(C2) represented a primary hepatocellular carcinoma (HCC) tumor sample embedded 
within C1. To evaluate the sensitivity to tissue parameters, a range of clinically-
relevant tissue properties were simulated.  To evaluate the impact of MWA antenna 
position, we simulated various tumor perfusion models with the antenna shifted 5 mm 
anteriorly and posteriorly.  To evaluate the effect of local vasculature, we simulated an 
additional heat-sink of various diameters and distances from the tumor. Dice 
coefficient statistics were used to evaluate ablation zone effects from these local heat 
sinks. The models showed less than 11% of volume variability (1 cm
3
 increase) in 
ablation treatment effect region when accounting for the difference in relative 
permittivity and electrical conductivity between malignant and healthy liver tissue. 
There was a 27% increase in volume when simulating thermal conductivity of fatty 
liver disease versus the baseline simulation. The ablation zone volume increased more 
than 36% when simulating cirrhotic surrounding liver tissue. Antenna placement 
relative to the tumor had minimal sensitivity to the absolute size of the treatment effect 
area, with less than 1.5 mm variation. However, when considering the overlap 
between the ablation zone and the ideal clinical margin when the antenna was 
displaced 5 mm anteriorly and posteriorly, there was approximately a 6 mm difference 
in the margins. Dice coefficient statistics showed as much as an 11% decrease in the 
ablation margin due to the presence of vessel heat sinks within the model. The results 
from simulating the variance in malignant tissue thermal and electrical properties will 
help guide better approximations for MWA treatments. The results suggest that 
  
assuming malignant and healthy liver tissues have similar dielectric properties is a 
reasonable first approximation. Antenna placement relative to the tumor has minimal 
impact on the absolute size of the ablation zone; yet it, does cause relevant variation 
between desired treatment margin and ablation zone.  Blood vessel cooling, especially 
hepatic vessels close to the region of interest may be a significant factor to consider in 
treatment planning. Further data needs to be collected for assessing treatment planning 
utility of modeling MWA in this context. 
Computational modeling techniques are under investigation for application to 
patient-specific planning of microwave ablation (MWA) treatments. Knowledge of the 
antenna design is necessary for accurate simulations; however, the proprietary design 
of applicators in clinical use is often unknown.  Characterizing the specific absorption 
rate (SAR) during MWA experimentally and comparing to a multi-physics simulation 
will provide a potential method for more accurately simulating MWA when the 
antenna geometry is unknown, as in most clinical situations.  To accomplish this, an 
infrared (IR) camera (Mikron M7500) was used to determine the spatial SAR during 
MWA within a split ex vivo liver model. Perseon Medical’s short-tip (ST) and long-tip 
(LT) MWA antenna were placed on top of a tissue sample. Microwave power (15W) 
was applied for 6 min, while intermittently interrupting power. Tissue surface 
temperature was recorded via IR camera (3.3 fps, 320x240 resolution). SAR was 
calculated from initial rate of temperature rise, and intermittently based on slope 
before and after power shut-down; these data were compared to SAR profiles 
calculated from simulations. Experimentally measured SAR changed considerably 
once tissue temperatures exceeded 100 ºC, contrary to simulation results. The 
  
simulation and average experimentally measured transverse and axial ablation 
diameters were 1.28cm and 1.30cm (+/- 0.0327cm) and 2.10 cm and 2.66cm (+/-
0.223cm); Dice coefficient was on average 0.832 (+/- 0.0248), suggesting good 
agreement with the simulated ablation zone. The viability of characterization for 
MWA antennas via measurements of the specific absorption rate (SAR) within tissue 
was demonstrated.  This method has potential for more accurately simulating MWA 
when the antenna geometry is unknown, as in most clinical situations.  
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CHAPTER 1 
 
INTRODUCTION 
 
Microwave ablation (MWA) treatment is an important, minimally invasive 
alternative to surgical resection of tumor in cancer treatment. However, the naive 
planning tools currently available are of limited practical use in real clinical decision 
making. These geometric planning guidelines are insufficient treatment planning tools 
for accounting for the level of unpredicted treatment variability seen during MWA 
procedures.  Unanticipated treatment variability may potentially be a cause of cancer 
recurrence, and it is difficult to measure treatment variability during MWA procedures 
on patients. Biothermal models have been employed to simulate these types of 
procedures and aid in quantifying the level of treatment variability seen in the 
clinically.  
In general, there are too many variables to measure and include for a patient-
specific physically-based simulation. A physically based simulation that accounts for 
tissue heterogeneities, perfusion, and temperature dependent effects will provide 
improved predictive accuracy over existing geometric models. Nevertheless, it is still 
unclear as to which parameters are important, and it we cannot measure their effect on 
real patients.  A potential solution to this problem would be to create a validated 
physically based simulation to simulate and explore the effect of a range of different 
patient specific variables so that we can focus on the most important ones. 
In order to help address the described problem the research reported in this 
manuscript will focus on discussing steps taken to 1) build and validate a MWA 
 2 
 
model, 2) investigate the variability in the physical parameters incorporated in MWA 
treatments, and 3) extend these methods to other devices with unknown geometry. The 
results of this research will be a critical component in developing ablation treatment 
planning and guidance tools for accurate and precise treatment delivery.  
Image-guided percutaneous MWA treatments can be guided by intraoperative 
ultrasound [1,2] or computed tomography (CT) fluoroscopy, which allows the 
physician to deliver treatments precisely. This precision and associated lower 
complication rates make ablation therapy a preferred alternative for high-risk patient 
populations such as the chronically ill and aged, who are not candidates for more 
invasive procedures such as surgical resection, radiotherapy, or chemotherapy[3,4,5]. 
However, rates of local recurrence after MWA are noted to be higher than hepatic 
resection. In some studies, image-guided thermal ablation for hepatocellular 
carcinoma (HCC) has recurrence rates as high as 50%, and image guided thermal 
ablation for primary lung cancer has up to a 30% recurrence rate, as confirmed on 
anatomical and functional imaging and/or repeat biopsy[6].  These recurrence rates are 
much higher than the reported 5-10% recurrence rates with resection or 
radiotherapy[7].  Figure 1.1 illustrates the  clinical goal for most MWA procedures 
,which is to ablate the entire tumor with an additional 5-10 mm margin along the 
entire circumference of the tumor to account for any residual cancerous cells that 
cannot be detected via imaging [8].  Nevertheless, in some areas where MWA is used 
to treat primary disease, such as the kidney, there are known risks for intraoperative 
complications that can lead to interruption and incomplete treatment [9].   
 3 
 
 
Figure 1.1:  Illustration of the  clinical goal for most MWA procedures ,which is to 
ablate the entire tumor with an additional 5-10 mm margin along the entire 
circumference of the tumor 
 
Incomplete treatment implies that the attempted ablation margin was not successfully 
achieved during the treatment.  Data review on over 64 MWA lung cancer treatment 
cases performed by our research group at Rhode Island Hospital between 2011 and 
2015 suggests a correlation between recurrence and lack of specificity in margin 
control. Furthermore, a potential source of incomplete treatment may be the variability 
for MWA procedures. I hypothesize that treatment variability can be explained 
through improved models and measurements of important physical characteristics 
during MWA. 
From the results of a pilot study performed by our group it is suggested that the 
vendor provided predictive planning tools are not sufficient for predicting treatment 
margins for all MWA treatments[10]. Currently, planning for MWA is done with 
vendor specification diagrams that provide estimates of expected ablation treatment 
region size as derived from experimental measurements in non-perfused animal tissue. 
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This approach ignores the effects of tissue perfusion, tumor type and location, and the 
influence of surrounding anatomy present in actual clinical procedures. Furthermore, 
the use of 2D ablation zone predictions on 3D anatomy places a considerable burden 
on the physician’s spatial treatment planning skill, and treatment accuracy may be 
skewed by physician experience.
 
When used for patient specific planning, this leads to 
inadequate predictions of the treatment coverage.  In preliminary work, we showed 
that such predictions have an average proportional error of 60% in total volume across 
20 clinical review cases[11].  To date, planning and intraoperative guidance for MWA 
remains highly subjective and dependent on individual physician clinical acumen, 
experience, and understanding of the engineering systems involved. The development 
of principled computational modeling tools for MWA will allow physicians to execute 
more complex procedures in shorter times and improve patient safety and treatment 
accuracy [12]. 
Biophysical models of tissue heating have been extensively employed for guiding 
the design and optimization of thermal ablation devices and treatment parameters (e.g. 
applied power levels, treatment time, single vs. multiple applicators)[13]. These 
modeling approaches have been extended and adapted for planning ablation 
procedures. Fuentes et al. used finite element models (FEM) informed by magnetic 
resonance imaging (MRI) datasets to compute current density and transient 
temperature profiles for radiofrequency ablation (RFA) planning[14]. Their study used 
a range of physically realistic blood perfusion parameters in a computer simulation to 
predict ablation lesions measured in vitro in perfused bovine liver models.  Their 
platform has potential for pre-operative evaluation of ablation margin assessment 
 5 
 
within tissue (via simulation) with idea of creating a treatment planning tool. 
Nevertheless, their developed platform cannot predict MWA treatment outcomes due 
to the difference in electromagnetic power deposition, heating pattern, and duration of 
heating between RFA and MWA.  Zhai et al. proposed a platform for preoperative 
surgery planning for percutaneous hepatic MWA that uses an iterative technique for 
necrosis field simulation and 3D necrosis zone reconstruction [15].  This method has 
the potential to be useful in assisting clinicians with pre-operatively assessment of 
insertion trajectory for MWA applicators; however, it had limited accuracy for 
predicting the size of the ablation zone when compared to post treatment evaluation.    
The data presented in this manuscript will aid in developing ablation treatment 
planning and guidance tools for accurate and precise treatment delivery.  Chapter 2 
will be a review of MWA, highlighting established key concepts in the context f 
modeling and treatment planning.  Chapter 3 will focuses on presenting a methods and 
results for building  and validating a model for simulating MWA procedures for a 
clinically used system (in which the geometry and physical parameters are provided). 
Chapter 4 will present data on investigating the variability in the physical parameters 
incorporated in MWA treatments.  While computational models afford the flexibility 
for including detailed tissue anatomy and heterogeneity, a balance between model 
complexity, accuracy, and required computational resources must be struck for 
practical clinical application. Investigating the most important contributing physical 
factors that affect MWA treatments via simulations may potentially provide guidelines 
for the level of detail needed for patient-specific modeling of MWA procedures. 
Chapter 5 will discuss a methodology for potentially extend these simulation methods 
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to other devices with unknown geometry by investigating alternative techniques for 
providing thermal spatial estimates during MWA procedure.  This will involve 
measuring how the tissue absorbs energy during MWA procedures for that particular 
antenna.  
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CHAPTER 2 
 
MICROWAVE ABLATION REVIEW 
Microwave Ablation Cancer Treatments  
Microwave thermal ablation (MWA) treatment is an important, minimally 
invasive alternative to surgical resection. These procedures involve the use of a 
microwave antenna (or an array of antennas) to deliver energy to raise tissue 
temperature above a thermal threshold to induce irreversible cell damage. Figure 2.1 
illustrates a typical MWA procedure within tissue using a single applicator.  
Commonly used clinical MWA systems operate at frequencies of 2450 MHz and 915 
MHz  . Image-guided percutaneous MWA treatments can be guided by intraoperative 
ultrasound or computed tomography (CT) fluoroscopy, which allows the physician to 
deliver treatments precisely[1,2].   As such, image-guided  MWA has received 
substantial attention for the treatment of cancer in the past decade that is performed in 
combination with other therapies (radiation therapy) or used as an alternative to other 
more invasive procedures (surgical resection). There has been increasing interest in 
improving the efficacy and specificity of MWA through improving energy delivery 
and application techniques in this domain. This review chapter outlines clinical 
percutaneous MWA technology detailing concepts related to thermal dosimetry, the 
physics of microwave heating, modeling of MWA in tissue, and future goals of 
treatment planning in the context of image-guided MWA procedures.  
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   (A)      (B) 
Figure 2.1: (A) Schematic and (B) gross specimen of a thermal ablation procedure on 
liver parenchyma.  A central zone of high temperatures (greater than 60°C, can exceed 
100°C) is created in tissue immediately around the applicator, and it is surrounded by 
more peripheral zones of lower tissue heating (Figure originally produced by [3]). 
 
Thermal Dosimetry 
Thermal dosimetry is a concept that relates and parameterizes thresholds for 
thermal damage into other contributing factors that can influence the damage done to 
tissue.  There are basic principles that govern the relationships between thermal 
exposure, including temperature and time of exposure. In addition, there are thermal 
damage factors influencing the time-temperature-damage relationships for thermal 
damage. Thresholds for thermal damage for a range of tissues, and their relationship 
with temperature-time were derived from cell survival studies[4]. 
Cell Survival Studies 
Numerous in vitro studies show that the rate of cell killing during exposure to 
heat is exponential and dependent on the temperature and length of exposure. Figure 
2.2 (A) shows examples of cell survival curves of Chinese hampster ovary (CHO) 
generated by Dewey et al[5].  Figure 2.2 (B) shows cell survival curves of human 
 10 
 
melanoma tumor cell line (HTB-66) [6]. Both curves cover a range from 42–45 ◦C and 
the heating times were up to approximately 5 hours.  
 
   (A)      (B) 
Figure 2.2: Survival of Chinese hamster ovary (CHO) cells over a range of 
temperatures (A; Data taken from Dewey et al [5] ). Survival of human melanoma 
cells heated over a range of temperatures. (Figure originally produced by Roizin-
Towle and Pirro [6].) 
 
These survival curves typically have a shoulder. This shoulder region is important, 
because it is evidence that shows there is a threshold for thermal damage to cells. 
From this study it can be seen that the width of the shoulder region varies with cell 
line, and is dependent upon temperature. After the initial temperature-time threshold is 
reached, cytotoxicity starts to occur, and the rate of cell killing begins to have an 
exponential dependence on temperature. For this study, there is little cytotoxicity for 
up to 5 hours of heating at 42 
◦
C. At 42.5 
◦
C, however, cell death was achieved after 5 
hours of heating. The hamster ovary and human melanoma cell lines showed a 
reduction in slope of the cytotoxicity curve after 4 hours of heating at 42.5 
◦
C and 3 
hours of heating at 43 
◦
C, respectively. This phenomenon is explained by the acquired 
resistance to heating or thermotolerance.  
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Sapareto-Dewey Thermal Dose Model 
With the rapid development of clinical hyperthermia for the treatment of cancer 
either alone or in conjunction with other modalities, a common way of comparing the 
heating effect between thermal therapies for an intended isothermal effect was needed. 
In addition, the non-uniform heating during the procedure caused spatial variations in 
temperature that need to be quantified and compared. During a typical hyperthermia 
treatment temperatures can vary from 37
◦ 
C – 43 ◦C within the same tumor [4,6,7,8]. 
Moreover, clinical temperatures could be even higher in some cases, and the duration 
of treatment and the frequency can also vary. 
A method for converting one temperature-time combination to another was 
presented by Sapareto and Dewey et al [9]. The method they proposed, converted 
temperature-time data into an equivalent number of minutes at 43 
◦
C. From their study 
the choice of 43
◦
C as the index temperature was based on the temperature  needed for 
several cell lines to break. Equation 2.1 shows the temperature-time conversation 
equation; 
                            (2.1) 
where CEM 43
◦
C is the cumulative number of equivalent minutes at 43
◦
C, t is the time 
interval (minutes), T is the average temperature during time interval t, and R is the 
number of minutes needed to compensate for a 1
◦
C temperature change either above or 
below the breakpoint (either 0.5 above 43 
◦
C or 0.25 below 43
◦
C).  The equation 
shows that if there is a temporal variation in the temperature of specific tissue, the 
time at each temperature must be determined, and the CEM 43
◦
C is then summed over 
all time intervals. Consequently, the CEM 43
◦
C is more representative of the entire 
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history of thermal exposure. It is important to note that the determination of R is based 
on previously presented experimental data such as Figure 2.2.  
A primary advantage of using the CEM 43
◦
C dosimetric unit is that it is not 
necessary to determine thresholds for damage of a particular tissue at every possible 
temperature-time combination. If thermal damage is well defined at one temperature-
time combination, the results can be extrapolated to define an isoeffect line that will 
establish exposure time boundaries for that specific tissue at any temperature. 
However, there may be extrapolation inaccuracies using the CEM 43
◦
C system at 
relatively low and high temperatures (below 40
◦
C or above 60
◦
C) due to insufficient 
data at these temperatures. Additionally, this method is based on the assumption that 
the R values for the CEM 43
◦
C are constant across a range of tissues. Although a 
reasonable assumption, more experimental work needs to be done when modeling 
specific temperature-time effects across different tissues [10]. Moreover, Sapareto et 
al. and Li et al. suggested that the cellular development of thermotolerance is what 
causes the “step down” effect in which exposure to temperatures above 43°C prevents 
the development of thermotolerance, thus allowing faster cell killing after subsequent 
exposure to temperatures below 43 °C[11,12] This phenomenon affects the calculation 
of accumulated dose. The development of thermal tolerance by cells also makes it 
difficult to use CEM 43 °C to calculate total thermal dose when multiple heat doses 
are applied. 
 
 
Arrhenius Thermal Damage Model 
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Many authors in the thermal therapy domain have used curves, derived from cell 
survival data noted in the previous section, to determine the heat of inactivation of 
cells.  This approach is called the Arrhenius analysis approach. This is done by 
plotting the rate of cell killing (1/Do). The parameter , Do,  is defined as the number of 
minutes to reduce survival by 63%  (1/e) on the exponential portion of the survival 
curve [13]. An example of such a curve is depicted in Figure 2.3. The heat of 
inactivation, K (kcal/mole) , is calculated using Equation 2.2 
             (2.2) 
 
Figure 2.3: Comparison of Arrhenius plots for a series of rodent and human cell lines, 
derived from cell survival curve data. The Arrhenius plots consider the rate of cell 
killing at an exponential rate. The rodent cell lines included in this figure are CHO, 
AD-%, C3H 10T-1/2: Human cell lines are KB7, MIA-PACA2, glioblastoma, WiDR, 
AG-1522, HTB66, HTB72, KB8 and A549. (Data from a paper by Roizin-Towle and 
Pirro [6]) 
 
where E is the  heat of inactivation (kcal/mole), A is a constant that is assumed to be 
unchanged over the temperature range studied, R is the molar gas constant (1.987 x 
10
-3
 Kcal/mole-K) and T is the absolute temperature in K.  
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These Arrhenius curves typically have a major change in their slope at a point 
(the break point) in which the slope tends to be steeper below the break than above it. 
The inactivation energy for the temperature range above the break point is typically 
around 120–150 kcal/mole.  This energy range is consistent with the heat of 
inactivation of proteins and enzymes [7]. The change in slope of the Arrhenius plot 
below the breakpoint is generally thought to be related to the development of acquired 
thermotolerance during heating[8]. When heating is delivered at temperatures above 
the breakpoint, thermotolerance does not occur during the heating period. It should be 
kept in mind, however, that thermotolerance does develop after heating at 
temperatures above and below the breakpoint. It can be seen from the Arrhenius plots 
that human cells have a higher breakpoint than rodent cells and therefore develop 
thermotolerance at a higher temperature. These characteristic differences in the 
Arrhenius plot between human and rodent cells indicate that human cells are more 
thermally resistant than rodent cells. This type of thermal sensitivity analysis is 
necessary in understanding the relationship between applied thermal energy and 
biochemical effects. 
Arrhenius data have also been derived from a large number of invivo studies. In 
this case, the endpoint is usually the time to reach an isoeffect, at a defined 
temperature. Moritz and Henriques et al. and Stoll and Greene et al. performed such 
studies they analyzed time–temperature relationships needed to create skin burn 
effects in human and pig skin, over a wide range of temperatures( Figure 2.4 and 
Table 2.1) [14,15] 
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Figure 2.4: Time–temperature combinations to achieve varying thresholds of thermal 
damage to human skin. Data obtained from Moritz and Henriques and Stoll and 
Greene[14,15]. 
 
 
Table 2.1: Activation energies calculated from double exponential fits to data from 
Figure 2.4.The breakpoints were 47 
◦
C for man and pig and 42.58 
◦
C for mouse. 
 
 
The relative resistance of human tissues to thermal damage is significant when it 
comes to relating thermal exposure to thermal damage from the skin burn data shown 
above. Nevertheless, factors, such as time and temperature, can be controlled during 
clinical thermal energy delivery methods such as hyperthermia. Temperature and time 
greatly contribute to the rate of cell killing. This fact has led groups to investigate 
methods of normalizing data of heating at different temperatures for different periods 
of time to a common unit that would allow for comparison of different heating 
techniques (i.e. Sapareto and Dewey model) 
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Physics of Microwave Heating 
Governing Physical Equations 
The equations that govern microwave heating of a material are Maxwell’s 
equations, which govern the propagation of the microwave radiation, and the forced 
heat equation, which governs the absorption and diffusion of heat by the material. If 
the material is assumed to be homogeneous, isotropic, and ohmic, ( that is the current 
and the displacement current, D, are proportional to the electric field, E,) and that the 
magnetic flux density, B, is proportional to the magnetic field strength, H, then 
Maxwell’s equations of electromagnetism are given by 
                                 
(2.3) 
     
 
  
               
 
  
         
 
where σ (S/m) is the electrical conductivity, ε (1) is the electrical permittivity, and μ 
(H/m) is the magnetic permeability[16,17]. In general, all the material properties are 
temperature-dependent.  For the heating of a three dimensional system, the 
electromagnetic wave propagation described in equation set 2.3 are functions of the 
spatial coordinate, x, y, z, and time with the  net free charge, ρ,  being zero[18].  As a 
result, Maxwell’s equations reduce to 
      
           
     
  
   
      (2.4) 
Where, μr is the relative permeability ratio, E is the electric field, k0 is the propagation 
constant in free-space, εr is the relative permittivity ratio, σ is the electrical 
conductivity, ε0 is the permittivity in free-space, and ω is the frequency in 
radians/second. As described earlier, several of the material parameters in equation 2.4 
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are dynamic with temperature. Thus this equation is temperature-dependent and is 
coupled with the forced heat transfer equation: 
     
  
  
             (2.5) 
where, k (W/m-K) is the thermal conductivity, c (J/kg-K) is the specific heat,  Q 
(W/m
3
 ) is the heat deposition term, and ρ (kg/m3) is the density and is often assumed 
to be constant. The first time on the right hand side of equation 2.5 is known as the 
thermal conductive term. This term describes the thermal conductance from local 
thermal gradients that result from physical interactions between particles of different 
temperatures within the medium of interest. The second term describes resultant 
thermal energy deposited via electromagnetic field propagation from a microwave 
energy source. [19]. 
When investigating the energy transmitted via an electromagnetic field, 
Poynting’s theorem can be used. Poynting’s theorem describes conservation of energy 
in a volume contained within a closed surface and can be expressed as 
 
  
                                   (2.6) 
The volume integral in equation 2.6 has terms representing the instantaneous energy 
stored in the electric field, in the magnetic field, and that possessed by charged 
particles, and as such shows the instantaneous total energy within the enclosed 
volume. The Poynting vector term (   ), represents the power density, thereby 
describing the surface integral as the instantaneous total power passing out through the 
closed surface. Consequently, equation 2.6 shows that the time and rate of change of 
the total energy inside the volume (V) is equal to the total power passing through the 
 18 
 
surface (S). Since the time averaged energy stored in the electric and magnetic fields is 
zero for sinusoidal fields, then from equation 2.6 it follows that 
                     (2.7)  
Where the total average power (       ) passing into V through S, and Pcp is 
the total average power transferred to the charged particles within V. For steady state-
state sinusoidal fields 
         
    
 
 
  (2.8) 
The absorption of the power transferred, the specific absorption rate (SAR), is 
described by: 
    
 
  
 
  
  
  
 
  
 
  
   
  (2.9) 
SAR (W/kg) is defined as the time derivate of the increment energy (dW) absorbed by 
or dissipated in incremental mass (dm) contained within a volume element (dV) of a 
medium of density ρ. From equation 2.8, the whole region SAR and local SAR can be 
calculated with the following expressions[20] 
       
       
  
 
   
 
 (2.10) 
            
 
 
  
    
 
  
   
Dielectric Properties of Biological Tissue  
The transmission of electromagnetic energy is determined by the dielectric 
permittivity and magnetic permeability of the media in which the waves propagate. As 
such, the propagation of electromagnetic energy through biological tissue is an 
adaptation of the principles discussed in equations 2.4 and 2.5.  The magnetic 
permeability of biological tissues is approximately the same as vacuum. The dielectric 
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permittivity contains both a real and imaginary component, which are used to define 
the more common terms: relative permittivity and conductivity (see equation 2.5).  
Relative permittivity, εr, is the real part of the complex permittivity and 
quantifies the ability to store electrical energy relative to vacuum. It is frequently 
referred to as dielectric constant. however, since permittivity is quite variable 
depending on frequency, temperature and other factors in biological tissues, the term 
relative permittivity is a more accurate expression. 
The effective conductivity, σ, of a material is defined from the imaginary part of 
the complex permittivity and is used to describe how well a material absorbs 
microwave energy. It is important to note that effective conductivity describes 
contributions from moving charges (electrical current) and time-varying electric fields 
(displacement current), specifically the rotation of dipoles in the material as they 
attempt to align with and alternating electric field [21]. The latter contribution 
dominates for most biological tissues in the microwave spectrum. This rotation of 
dipoles generates heat inside of lossy materials such as biological tissues, which will 
be described next. 
Interactions of Microwaves within Tissue 
The most significant effect of an electromagnetic field applied to biological 
tissue is conversion of microwave energy to thermal energy. Heat transfer in tissue can 
be quantified using a variation of the forced heat equation (equation 2.5), known as the 
bioheat equation [22].
 
   
  
  
                 (2.11)
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As previously discussed, Q  is the applied heat rate via microwave to heat energy 
conversion, which is dictated  by the effective conductivity.  More specifically, the 
effective conductivity dictates how efficiently microwave energy is converted to heat, 
and is dependent primarily on the type of tissue, its water content, and the frequency 
of the applied field. The water content within biological tissue is the greatest 
constituent to the heating effect.  The atomic structure of water produces an electric 
dipole moment. When an electromagnetic field is applied water molecules continually 
rotate to align with the applied field. Kinetic energy increase as a result of this 
continuous realignment, thus elevating temperature. Consequently, conversion of 
microwave energy to thermal energy is directly correlated the amount of water within 
the region of interest [23]. 
Microwave field penetration into a tissue medium is also dependent on the 
dielectric properties of the tissue. The penetration depth, d (m), of the electromagnetic 
field of a plane wave travelling in a homogenous, isotropic medium, is quantified as 
the distance required for the electric field to attenuate to 1/e (approximately 37%) of 
its initial value[20]. More specifically, it is quantified by the relation 
  
 
     
 
 
         
    
 
 
  (2.12) 
where ω is angular frequency (rad/s) which is  equal to 2 πf, where f is frequency ( 
Hz), μ is magnetic permeability (H /m), and ε is dielectric permittivity (F /m).  
Assuming good dielectric ([σ/ωε]2 ≪ 1)  tissue (i.e. liver, kidney, and muscle) the 
penetration depth can be approximated with the more simplified relation 
  
 
 
 
 
 
    (2.13) 
 21 
 
which is a good first assumption for most tissues and microwave ablation frequencies.  
It is important to remember that penetration depth is inversely related to conductivity, 
but heating rate is proportional to conductivity. Therefore, deeper penetration occurs at 
the expense of slower heating. Energy conservation through the conversion of 
microwave energy to heat explains this, and is the major cause of field attenuation. 
Consequently, balancing penetration heat production and penetration depth is 
important for analyzing the most appropriate frequencies for specific applications.  
Higher frequencies have faster heating rates but shallower field penetration which is 
favorable for procedures that desire fast controlled heating such as thermal ablation 
[24].  Lower frequencies have slower heating rates but deeper field penetration which 
may be more desirable heating applications such as regional hyperthermia of larger 
volumes [25].  
It is important to note that much of the energy radiated by microwave antennas 
in lossy media such, as biological tissues, is absorbed near the antenna (also called the 
Fresnel zone). As such, the radiated energy may not propagate as a plane wave. In this 
case, the previously mentioned calculations of penetration depth can only be viewed as 
approximations. This is where simulations of electromagnetic and thermal interactions 
can provide more accurate temporal heating estimates[26]. Moreover, coupled 
electromagnetic-thermal simulations may be more enlightening than simple 
calculations considering only electromagnetic penetration. Curto et al. assessed the 
differences in MWA at 915 MHz and 2.45 GHz (the most common clinically used 
frequencies) and corroborated their simulation findings with experiements[27]. In this 
study 2.45 GHz yield larger ablation zone due to greater power deposition in 
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proximity to the antenna (for 5-10 minute heating durations). In addition, Luyen et al. 
showed faster heating rates with MWA antennas operating at 10.0 GHz antenna when 
compared to a 1.9 GHz antenna, suggesting that higher frequencies may offer the 
advantage of smaller antenna size [28].  However, at 10 GHz there was a slightly 
delayed onset of heating farther from the antenna, suggesting that heat conduction 
plays a greater role at higher microwave frequencies in achieving a comparably sized 
ablation zone.  Accurate modeling techniques are becoming increasingly important for 
analyzing the relationship among antenna design, power deposition, and heating 
efficiency of MWA.  
Modeling Microwave Ablation in Tissue 
Modeling Framework 
There are several different modeling approaches that have been discussed in the 
literature for simulating MWA procedures for the purpose of design and optimization 
of MWA devices [29-33].  Commonly used techniques include the finite element 
method (FEM), finite difference time domain, and the method of moments. 
Nevertheless, all approaches generate power deposition and heat dissipation solutions 
within the region of interest, and some incorporate potential confounders 
simultaneously.  For all modeling methods, a  mathematical framework that can 
simulate the two important physical processes in ablation are:  1) how energy radiated 
from the ablation device is deposited within the nearby tissue, and 2) how heat is then 
distributed within the tissue to cause a thermal damage effect.  Figure 2.5 illustrates a 
comprehensive theoretical modeling framework for  microwave tissue ablation [34]. 
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Figure 2.5: Flow of operations for a comprehensive theoretical model for microwave 
tissue ablation. The treatment may be terminated based on a thermal coverage of a pre-
specified region or after a given treatment time. 
 
Developing a MWA model involves integrating a prior knowledge of the 
physical characteristics of the tissue of interest into the solution. The requisite 
differential equations discussed previously are governed by the electromagnetic and 
thermal tissue properties of the target and their dependence on temperature [35,36], 
and the input power source of the ablation device at a specified frequency. Moreover, 
boundary conditions are also established within the simulation.  As stated in the 
previous section, several terms in Maxwell’s equations and the bioheat transfer 
equation implicitly depend on the relative permittivity, electric conductivity, thermal 
conductivity, specific heat, and other properties at the material interface between 
different media [37,38,39]. For every material boundary within the simulation a stable 
solution is generated, i.e. from the port in which the microwave signal is sent, through 
main conductor, and all the way to the medium in which the antenna is immersed.  As 
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the complexity of the simulation increases with the added variables, computational 
time increases as well. Furthermore, each variable also introduces additional 
uncertainty that must be carefully managed to preserve the accuracy of the simulation. 
Figure 2.6 is an illustration of a modeling geometry used for simulating a MWA 
experiment.  
 
 
 
Figure 2.6: An example MWA simulation geometry within liver generic dipole 
antenna. The presented geometry is and 2D axisymmetric model created within 
Comsol Multiphysics finite element software package[34]. 
Input Parameters 
Table 2.2 provides a list of some of typical thermal and electrical inputs used for 
a microwave procedure performed on a bovine liver model. Liver animal models are 
commonly for simulation and validation of MWA procedures on patients in the 
context of evaluating antenna performance [40,41]However, as previously discussed 
there is evidence of a dynamic temperature dependency of several thermal and 
electrical properties of tissue during MWA. 
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Table 2.2. List of static properties used in the homogenous liver simulations 
 
 
ε (1)  μ σ (S/m) κ  (W/m*K) ρ  (kg/m
3
) Cp (J/kg*K) 
Air 1 1 0 .0257 1.205 1000 
Liver/Tumor ε liver 1 σ liver .564 1038 3400 
Dielectric  2.1 1 0 0.5 1050 3600 
Copper 1 1 5.998 x 10
7
 400 8700 385 
 
The dynamic nature of dielectric tissue properties is evident from studies that 
have measured these properties during MWA experiments within liver and other tissue 
across a broad range of temperatures[42].  For example, temperature dependent 
measurements dielectric properties of liver tissue at 2450 MHz were performed by Ji 
and Brace et al. [43].  Figure 2.7 illustrates the measured results from this study.  
 
Figure 2.7: Experimental results (dots) of relative permittivity and conductivity versus 
temperature during microwave ablation at 2450 MHz. Also shown are the best-fit 
sigmoidal curves (solid lines), along with the upper and lower envelops (dashed lines) 
used for numerical simulation. Figure originally produced by Ji and Brace  [43]. 
 
Figure 2.7 shows tissue dielectric properties changing slowly below 70 °C as observed 
in previous studies by Lazebnik et al  Stauffer et al[44,45].  However, a rapid decrease 
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in both relative permittivity and conductivity is shown from 70 °C - 100 °C. At above 
100 °C, tissue relative permittivity and conductivity drops to values at about 10% of 
those at room temperature and remains there. From these measurements, mathematical 
parameterizations (based on best fit sigmoidal curves) have been derived to be 
incorporated as inputs for modeling MWA within tissue.   
For thermal conductivity, there are several approximation techniques that have 
been employed in modeling MWA within tissue.  For example, linear approximation 
are commonly used to reflect  increases in thermal conductivity from  the starting 
reference temperature (37 °C ) up to temperatures of 100°C[46]. Determination of the 
slope of increase is based on experimental data previously reported from experiments 
within the tissue of interest.  Similarly, temperature dependent specific heat capacity 
of tissue is implemented using the parameterization derived from previously reported 
data.
  
For specific heat, it is important that the parameterization reflects steep drops at 
temperatures above 90 °C that corresponds to the loss of tissue water[47]. 
Boundary Conditions 
First-order electromagnetic scattering boundary conditions are often used within 
the simulated MWA medium. These are governed by the PDEs described earlier. 
Moreover, thermal insulation boundary condition can also be applied at the model as 
well.  In addition, some MWA procedures use cooling systems to avoid excessive 
charring during MWA procedures within tissue. Often either fixed temperature 
boundary conditions or a convective cooling boundary condition is placed along the 
shaft of the antenna  to model the cooling. A similar approach has been used for 
modeling blood vessel cooling when modeling invivo MWA close to a vasculature. 
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Model Output 
Several metrics have been used as output metrics for MWA zone evaluation.  As 
previously discussed, Arrhenius tissue damage model has been used to estimate 
extents of the ablation zones.  Appropriate isotherms are often used as a first 
approximation to evaluate model output accuracy. Figure 2.8 is an example result of a 
MWA prediction of a procedure performed within the liver.  
 
Figure 2.8: Comparison of (a) ablation zone in created ex vivo bovine liver and (b) 
theoretically predicted temperature profiles using comprehensive theoretical 
simulation including dynamic changes in tissue properties. The 60 °C isotherm is in 
good agreement with visible boundary of coagulated tissue. (Figure original produced 
by [48]) 
 
Treatment Planning for Microwave Ablation 
There are groups that have developed simple tools for planning microwave 
ablation procedures; however these are all limited in clinical utility as they provide 
little more than visualizations of vendor specified geometric guides relative to the 
patient anatomy near the antenna.  Although this approach does provide some 3D 
information about likely treatment zone margins near the target, these estimates are 
known to be inaccurate in clinical situations. Figure 2.9 shows an illustration of these 
commonly used clinical treatment planning tools 
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Figure 2.9. Example of current geometric planning available for percutaneous 
microwave thermal ablation from the operator’s manual of Perseon and NeuWave 
ablation systems. 
 
Recently, there has been renewed interest in the development of accurate 
modeling techniques for predictive planning of MWA and other thermal therapies. 
Such models may help physicians in selecting treatment parameters (e.g. number of 
antennas, applied power levels, insertion paths) that maximize the likelihood of a 
desired treatment outcome. Predictive modeling tools are of particular clinical 
relevance due to the shortage of practical techniques for intra-operative monitoring of 
thermal damage. There have been attempts for developing treatment planning systems 
for thermal therapies. Challenges with the use of biophysical models for treatment 
planning include lack of knowledge of patient-specific tissue biophysical properties 
and clinical impracticality due to computational time constraints. 
Imaging data that is collected prior to and during ablation treatments has strong 
potential to inform biophysical models for treatment planning[49]. Computational 
models guided by imaging data offer the ability to determine the impact of tissue 
heterogeneity, blood perfusion, source/applicator positioning relative to the target, 
vascular cooling, and other parameters that can affect the size and shape of the 
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treatment effect region. A novel treatment planning system for high frequency 
ultrasound (HIFU) that uses this type of framework has been developed by Amin et al 
[50]. Their group used pre-treatment imaging (CT, MRI or ultrasound) for the 
segmentation of the  target and surrounding  anatomy.  From these segmentations, 3D 
anatomical models of the target and overlaying tissues were developed. That 
information was then used for ultrasound simulation of beam intensity distribution and 
HIFU temperature profiles. Figure 2.10 is an illustration of this inputs and results of 
this platform. 
 
Figure 2.10: (Upper left) Screen capture of the tools for DICOM image segmentation , 
(lower left) tissue model simulation, (right)  and ultrasound beam simulation.  
(Original figure in [50]). 
 
There have been several proposed systems for MWA pre-procedural planning 
[51,52]. Similar to the illustration in Figure 2.11, these MWA planning systems allow 
for 2D and 3D visualization of antenna position with respect to the target volume and 
surrounding anatomy.  This may provide some additional 
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Figure 2.11: 3D visualization of applicator placement with respect to tumor location 
and surrounding anatomy 
 
information that can be used by clinicians when discussing treatment approach, of 
which is not available in current planning standards. Although valid approaches, the 
referenced platforms lack imaging datasets as the basis for informing their MWA 
models of zone extents.  
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Introduction 
Microwave ablation (MWA) is a minimally-invasive modality that is playing an 
increasingly vital role in the treatment of cancer and benign disease. Over the past 
decade, MWA has been adopted as an alternative form of treatment for several 
primary and secondary tumor sites in liver 
1
, lung 
2
, kidney 
3
, and bone 
4
. These 
procedures require the use of a microwave antenna (also referred to as the ablation 
applicator) to deliver energy to raise the temperature of tissue above a threshold where 
irreversible cell damage occurs. Tissue injury following thermal exposure is a function 
of the time-temperature history during heating 
5
. Other energy modalities in clinical 
use for tumor ablation include radiofrequency current, lasers, ultrasound, cryoablation, 
and non-thermal irreversible electroporation. Although MWA has its advantages as a 
cancer treatment, there are still many unknowns with regard to the energy dissipation 
from the antenna, as well as biophysical effects in tissue adjacent to the antenna and at 
the treatment margin.  
Mathematical models of the processes that occur during MWA have been 
employed during the design and optimization of devices for MWA 
6, 7, 8, 9, 10
. These 
models use numerical techniques to solve the partial differential equations which 
govern electromagnetic propagation, power deposition, and bioheat transfer 
11, 12
. 
Commonly used numerical techniques for solution of these equations include the finite 
element method (FEM), finite difference time domain (FDTD), and the method of 
moments (MoM). Analytical methods for approximating microwave power deposition 
and bioheat transfer have also been reported 
13
. Recently, there has been renewed 
interest in the development of more accurate modeling techniques for predictive 
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planning of ablation treatments. Such models may help physicians to choose the 
treatment parameters (e.g. number of antennas, applied power levels, antenna insertion 
paths) which maximize the likelihood of a desired treatment outcome. Predictive 
modeling tools are of particular clinical relevance due to the shortage of practical 
techniques for intra-operative monitoring of thermal damage. While MRI does provide 
a means for volumetric thermometry, at present the added cost and technical 
complexity make it impractical for routine clinical use 
14, 15
.   
Microwave systems and antenna designs for thermal ablation have evolved from 
systems originally designed for interstitial hyperthermia (moderate heating of targeted 
tissue for ~40 < T < 46 °C) as an adjuvant to radiation/chemotherapy 
16
. Currently, 
clinical ablation systems operate at frequencies of 915 MHz and 2.45 GHz. 
Computational models of interstitial microwave hyperthermia devices, which account 
for electromagnetic energy deposition and bioheat transfer at temperatures slightly 
above core temperature, have been extended for modeling of the higher temperatures 
required in thermal ablation. Recent accomplishments include: (a) measurement and 
incorporation of dynamic changes in tissue dielectric properties as a function of tissue 
temperature within computer models 
17,18
, (b) accounting for electrical and thermal 
changes in the tissue properties due to the movement and phase change of water 
during ablation 
19, 20, 21
, (c) modeling the temperature-dependent changes in blood 
perfusion 
22,23
, and (d) modeling the heat-induced tissue shrinkage 
24
. However, most 
measurements of the temperature dependence of the electromagnetic properties of 
tissues in addition to modeling studies have been focused at 2.45 GHz. Most 
computational models of microwave ablation systems for 915 MHz have assumed 
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static tissue dielectric properties and energy deposition profiles during ablation 
23, 25, 26, 
27
. Furthermore, there are no definitive measurements of the thermal and dielectric 
properties of tissue residues at temperatures well above 150 °C which occur near the 
antenna during MWA.  
There is a need for improved models to determine the spatiotemporal profile of 
electromagnetic energy deposition and bioheat transfer during 915 MHz microwave 
ablation. These models will provide further insight into the dynamics of ablation 
treatments, and thereby enable improved device and system design. Furthermore, 
accurate theoretical models have a strong potential for characterizing the thermal dose 
distribution during ablation, as well as for prospective treatment planning. The 
objective of this study is to formulate, develop, and experimentally verify a 
computational modeling platform for simulating microwave ablation with a 915 MHz 
clinical ablation antenna (Perseon Short Tip (ST) antenna). The impact of dynamic 
changes in tissue electrical and thermal properties on predicted ablation volume 
outcome will be investigated. The proposed modeling platform will provide more 
insight into simulating the biophysical phenomena during 915 MHz microwave 
ablation.  
 
Methods 
Modeling the Physical Processes during Microwave Ablation 
During MWA, an antenna is introduced into the target tissue under image 
guidance, and the induced electric field heats the tissue. As the tissue temperature 
increases, temperature-dependent electrical and thermal properties of the tissue may 
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change: (1) impedance matching between the ablation device and the tissue; (2) the 
pattern of microwave heating by the antenna; and (3) bioheat transfer. At temperatures 
in excess of 60 °C, tissue desiccation, water vaporization, and shrinkage have a 
significant impact on the induced temperature profile 
28
.  
In this study, we employed the FEM (implemented with COMSOL 
Multiphysics, v4.4) to simulate MWA with the 915 MHz Perseon ST antenna.  First, 
we assigned values for the material properties of the tissue as well as components of 
the antenna at the initial temperature. The Helmholtz wave equation was then solved 
to determine the electric field radiated by the antenna. Next the temperature was 
determined with Pennes’ bioheat equation. Then the material properties were 
determined at the new temperature.  This process was repeated iteratively while 
reducing the size of the time step until the electric field and temperature converged. 
Then this process was repeated for steps until reaching the specified duration for the 
treatment. Equations 3.1 and 3.2 show the two processes in each step.  
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In (1), μr is the relative permeability ratio which is unity for all of the materials in this 
model, E [V m
-1
] is the electric field, k0 is the propagation constant in free-space, εr is 
relative permittivity ratio, σ [S m-1] is electrical conductivity, ε0 [F/m] is the 
permittivity of free-space, and ω[rad s-1] is angular frequency.  In (2), ρ [kg m-3] is the 
density, Cp  [J kg
-1
 ºC
-1
] is the heat capacity at constant pressure for the tissue, T [ºC] 
is the temperature, k [W m
-1
 ºC
-1] is the thermal conductivity, ρb is the density of the 
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blood, Cb is the heat capacity at constant pressure for the blood, ωb [s
-1
] is the 
perfusion rate, and Tb is the temperature of blood. 
Boundary Conditions and their Significance 
 
A 2D rotationally-symmetric model was employed in this study (see Figure 3.1). 
A thermal insulating boundary condition and a first-order electromagnetic scattering 
boundary condition were applied at the outer edges of the model shown in Figure 3.1.   
 
 
Figure 3.1. Illustration of the model geometry for simulating MWA with the Perseon 
ST applicator. 
The electrical properties of all parts of the applicator were specified in the model, 
including the highly conductive metallic regions of the applicator (i.e., no perfect 
electrical conductor regions were assumed). Our measurements indicated 
approximately 1/3 of the generator power is dissipated within the cables connecting 
the microwave generator to the antenna. The input power was specified at the antenna 
port shown at the top of Figure 3.1, allowing for this attenuation. A thermal insulation 
boundary condition was applied at the outer surface of the model.  
To approximate saline cooling of the proximal end of the antenna, the inside 
metal shaft of the applicator was assigned a fixed temperature boundary condition of 
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40 ºC. Table 3.1 shows a compiled list of the electrical and thermal properties used in 
the simulation as well as their nominal values at approximately 37 ºC. 
Table 3.1. Material properties used within FEM simulations 
Symbol Quantity Nominal Value (37 ºC) 
  Liver      Plastic      Metal 
Electric Properties   
εr dielectric constant  46.8         2.2         1.0 
σ electrical conductivity  [S/m]  0.86         0            5.96 x 107 
Thermal Properties   
κ thermal conductivity [W m-1 ºC -1]  0.52         0.3         400 
Cp specific heat capacity  [J kg
-1 ºC -1]  4187        1000     400 
ρ Density  [kg m-3]  1000        2200     8900 
Perfusion    
ωb Perfusion rate  [s
-1]  0.0036     N/A       N/A 
ρb Blood density [kg m
-3] 1025         N/A       N/A 
Cb Blood specific heat [J kg
-1 ºC -1]     N/A       N/A 
 
Material Property Characterization 
 
We make the approximation that, at any point in time, the material properties of 
the liver depend only upon the instantaneous temperature.  The change in the 
properties caused by heating is due to chemical reactions including pyrolysis as well 
as water loss by the tissues 
19
.  Since the simulations do not continue after the 
microwave power is turned off, the temperature increases monotonically with time. 
Several groups have reported experimental measurements of the dielectric 
properties of liver at 2.45 GHz changing as a result of water loss at elevated 
temperatures during microwave ablation 
17,18,19
, data are not available at 915 MHz. Ji 
and Brace
17
 employed a best-fit sigmoid of their data to approximate the electrical 
conductivity and dielectric constant of liver at 2.45 GHz as a function of the local 
temperature during ablation. We have followed and extend their efforts in this study.  
Our expression for the electrical conductivity of liver at 915 MHz is a first 
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approximation to include the effects of the chemical changes in an ablation which 
cause char and other products at high temperatures where little data for these 
properties is available. Equations 3.3 and 3.4 show the parameterization for electrical 
conductivity and relative permittivity used in our simulations. These expressions are 
approximately a sigmoid, similar to that employed by Ji and Brace
17
, with our 
estimates of the values at the higher temperatures. 
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The parameterization for approximation of the thermal conductivity is also 
temperature dependent. Thermal conductivity was defined as: 0.526 W m
-1
 ºC
-1
 at 20 
ºC, 0.52 W m
-1
 ºC
-1
 at 50 ºC, 0.48  W m
-1
 ºC
-1 
at 80 ºC to, 0.4 W m
-1
 ºC
-1
 at 100 ºC, .37 
W m
-1
 ºC
-1
  at 130 ºC, with linear interpolation used to determine values at 
intermediate temperatures, and 0.36 W m
-1
 ºC
-1
 at 200 ºC allow for the presence of 
char. This parameterization captures the initial roll-off in the thermal conductivity of 
liver followed by a plateau caused by the formation of char at high temperatures. 
Equation 3.5 shows the temperature-dependency of the specific heat capacity used in 
our simulation. A Gaussian function centered at the boiling point of water is used to 
simulate the added heat sink associated with tissue water evaporation
21
.  
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To approximate the effects of microvascular stasis at elevated temperatures, the blood 
perfusion term was gradually reduced to zero at ablative temperatures
22
. This 
approximation was done over a temperature range; where at Tlow=50  ºC, ωb =0.016 s
-
1
; at T = 60  ºC, ωb = .0157 s
-1
; at Thi>65  ºC s
-1
, ωb = 0. Linear interpolation with 
constant extrapolation was used in these simulations.    
Ablation Zone Evaluation 
 
The Arrhenius tissue damage model was used to estimate extents of the ablation 
zone (frequency factor A = 3.18 x10
55
 s
-1
 and an activation energy ΔE = 3.513 x105 J 
mol
-1) 29, 30
. For the 10-15 min ablation durations considered in this study, ablation 
zone extents derived from the 50 ºC isotherm were compared to calculations using the 
Arrhenius equation with a frequency factor
31,32
. The Arrhenius equation was only used 
as a posteriori, and not in determining changes in the electrical and thermal properties 
of the tissue.  
Model Validation and Measurements  
 
Fresh bovine liver was acquired from a local abattoir and transferred to the lab in 
sealed plastic bags placed on ice.  The liver was then warmed to ~37 ºC in sealed 
plastic bags placed within a temperature-controlled bath. Once the liver sample was 
warmed, the tip of the applicator was precisely inserted 6 cm proximal to the liver 
surface. Temperature probes (Neoptix, RFX-04-1, Canada) were placed 5 mm, 10 
mm, 15 mm and 20 mm radially away from the antenna at 6 cm depth from the 
proximal liver surface. MWA experiments were performed for 10 and 15 minutes, at 
applied power levels of 30 and 60 W, respectively.  Temperature measurements were 
recorded for the duration of all ablation experiments.  
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The peak temperature during microwave ablation (i.e. immediately adjacent to 
the ablation applicator) is difficult to measure. Most experimental studies report 
temperature measurements at distances greater than 5 mm radially from the applicator 
surface
17,18]
. Temperatures in excess of 120 ºC have been experimentally reported 
23
. 
Due to the steep electric field gradients in proximity to the antenna, it is not 
unreasonable to expect temperatures in excess of 200 ºC immediately adjacent to the 
antenna. Nevertheless, to test the hypothesis of maximum temperatures exceeding 200 
ºC during MWA, we performed experiments in which pieces of solder (with melting 
points up to 220 ºC) were placed in proximity to the MWA antenna during 60 W 
ablations. The results of this would provide more insight into maximum temperatures 
reached during MWA and aid simulations.  
Post ablation, a fine cut was made axially down the center off the ablated region 
using the antenna as a guide.  Measurement of the ablation zone transverse and axial 
diameters were recorded from the cut liver samples.  In addition, measurements of 
tissue dielectric properties post ablation were performed at different tissue locations 
using a high-temperature dielectric measurement probe (HP 85070A) and a vector 
network analyzer (HP 8753D). Each measurement location represented a region of 
specific discoloration of the tissue caused by the ablation, including  “charred” , 
“brown”, and “pink”, as well as the “outside region” of non-ablated tissue. In addition, 
a pre-ablation measurement was taken on the liver surface as a control. For these 
measurements, the dielectric measurement probe was pressed at the surface of the 
measurement site. The probe surface was wiped clean with an alcohol wipe, and 
allowed to dry, in between each dielectric measurement taken in the discussed ablation 
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regions. Electrical conductivity and permittivity measurements at 915 MHz and 2.45 
GHz are reported. 
Results 
Figure 3.2 shows simulated temperature maps following 60 W ablation for a 
duration of 5, 10, and 15 min. Figure 3.3 depicts the ablation zone following a 60 W 
15 minute experiment in ex vivo bovine liver.  Measurements of the ablation zone 
axial and transverse diameters after 60 W 15 minute ablation experiments and 30 W 
10 minute ablation experiments are shown in Table 3.2.  
 Figure 3.2 Temperature maps( from in vivo simulations) and ablation extents for 60 
W ablations at (A) 5 min, (B) 10 min, and (C) 15 min 
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Figure 3.3 Axial cut of a 60 W 15 ablation on an exvivo liver sample. 
 
Figure 3.4 is a simulation and ex vivo experiment comparison plot of the temperature 
change during ablation at various radial position form the applicator during 15 min, 60 
W ablation experiments. The simulated transverse and axial diameters are presented in 
Table 3.2, as well as the difference from the simulated axial and transverse ablation 
extents. 
 
Figure 3.4. Temperature rise during in ex vivo liver vs radial position at (a) 1 min, (b) 
4 min, (c) 8 min, and (d) 15 min, during a 60 W experiment.  
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Table 3.2. Measurements of the ablation zone axial and transverse diameters after 60 
W 15 minute ablation experiments and 30 W 10 minute ablation experiments. The 
simulated transverse and axial diameters are presented, as well as the percent 
difference from the simulated axial and transverse ablation extents is shown.  
 
       
Experiment # 
              60W 15 min       30 W 10 min                           
     Transv. (cm)     Axial   (cm) Transv (cm)     Axial (cm)               
1      3.5                     4.3    2.4                   3.4 
2      3.9                      4.1    2.8                  3.1 
3      3.7                      4.5    2.3                  3.4 
4      3.25                    3.9     2.5                  3.6 
5      3.4                     4.6     -                      - 
6      3.4                     3.9     -                      - 
7      3.2                     4.0     -                      - 
8      3.6                     4.0      -                      - 
Average      3.53                   4.22     2.5                   3.5 
Simulation             3.54                    4.82       2.58                 3.52 
%Diff from 
Experiment 
         0.43                  15.15                  3.15                0.57 
   
 
Figure 3.5. Post ablation position of dielectric measurements. Each region represents 
discoloration of tissue that occurs during  ablation experiments, signifying a chemical 
change ( charred region, brown, pink, and outside)  
 
The average and standard deviation of the measured dielectric constant and 
electrical conductivity of ablation zone regions depicted in Figure 3.5 are shown in 
Table 3.3. The results of the maximum MWA temperature experiments showed that 
pieces of solder with melting points up to 220 ºC that were placed in proximity to the 
device were melted during the course of an ablation. Figure 3.6 shows a log-log plot of 
the volumetric power absorbed (Q) within liver tissue and radial electric field (Er) as a 
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function of radial distance. Figure 3.7 shows the simulated spatial distribution of 
temperature from simulations made using dynamic (temperature-dependent) tissue 
properties vs. static properties.  Here the 50 ºC temperature contour is also shown as 
an approximation to the extent of the ablation.   
 
 
Table 3.3. Measurements of the dielectric constant and electrical conductivity of 
various ablation zone regions at 915 MHz and 2.45 GHz. 
 
Region of 
excised Liver 
                915 MHz               2450 MHz 
           εr                σ [S/m]   ε r                 σ  [S/m] 
Liver Surface        36.96                0.78   35.37                  1.13 
(Pre-Ablation)         
 
 3.20                
 
 0.06    
 
 3.36               
 
  0.07 
   
Outside Region        34.41                 0.80    32.50                 1.17 
          
 
 1.28                
 
 0.05    
 
 1.43               
 
  0.12 
   
Pink        27.94                 0.68    26.32                 0.98 
        
 
  1.28                
 
  0.05         
 
 2.03               
 
  0.13 
   
Brown        16.47                 0.36          15.83                 
0.53 
      
 
 
 11.31                
 
  6.06         
 
 10.52             
 
  0.46 
   
Charred         1.58                 0.01          1.58                 0.02 
        
 
 
 0.44                 
 
 0.01          
 
 0.36              
 
  0.01 
   
  
 
 
 
 
Figure 3.6. Radial plots of (A) Q and (B)  Er at the onset of the treatment, 5 min, 10 
min, and 15 min on logarithmic axes. These data were gathered from an in vivo 
simulation. 
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Figure 3.7. Simulations of 60W 15 minute treatments of perfused liver using shot-tip 
applicator. Simulated spatial temperature outputs from the model using(a) dynamic 
properties and (b) static properties,  with 50 ºC temperature contour overlaid to 
approximate the extent of ablation zone.   
 
Discusion 
The objective of this study was to formulate, develop, and experimentally verify 
a computational modeling platform for simulating MWA with a clinical 915 MHz 
ablation system. To accomplish this, the impact of dynamic changes in tissue electrical 
and thermal properties on transient temperature profiles and predicted ablation volume 
outcome were investigated. Results from computational models were compared with 
data from experiments in ex vivo tissue. Modeling results were used to analyze 
evolution of the energy deposition profile and ablation zone during heating. 
The in vivo 60 W simulation ablation extents, depicted in Figure 3.2 by the 50 ºC 
isothermal contour, show agreement with the estimates of the ablation zone made 
using the Arrhenius thermal damage model. Other studies have made similar 
comparisons between simulation and experimentally observed ablation extents in the 
temperature range of 50 – 52 ºC which are also in agreement with thermal dose 
metrics for several tissue types 
32, 33, 34
. The measurements of the ablation zones for the 
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60 W 15 minute and 30 W 10 minute ex vivo experiments reported in Table 3.2 show 
good agreement with the simulated ablation extent. Specifically, 30 W simulated axial 
length and transverse ablation diameter were both within 1 mm when compared to the 
experimentally measured ablation extents. Furthermore, the 60 W simulation axial 
length and transverse ablation diameter were within 2.5 mm and 1 mm respectively 
when compared to the measurements. It is important to note that for all ex vivo 
experiments the sharp cut off in the charring along the central axis, due to the 
applicator cooling system seen in Fig 3.2, is also seen in the associated simulation.  As 
expected, the in-vivo simulation shown in Figure 3.2 has a smaller ablation zone when 
compared to the ex vivo simulation because of heat dissipation via perfusion. These 
results suggest that simplified computational models, such as the one used in this 
study, have potential for predicting ablation zone dimensions.  
Figure 3.4 depicts temperature change from the starting temperature measured 
by fiber optic probes placed at 5, 10, 15, and 20 mm from the antenna, compared to 
the simulated temperature change at the same radial positions.  In general, the 
experimentally measured radial temperature profiles (i.e. temperature slope in the 
radial direction) are in agreement with simulated profiles (within 2-8 ºC) although the 
numerical values do not align. We hypothesize that this discrepancy may be due to: (1) 
unknown tissue material properties and inter-sample variations, and (2) uncertainty in 
the position of the temperature sensor over the course of the ablation duration. 
Moreover, these curves illustrate that the change in slope of temperature for a 
particular radial position is more pronounced at time points at the beginning of 
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ablation, and has much less of an influence on the temperature slope at the end of 
ablation.  
The hypothesis that it is not unreasonable to expect temperatures in excess of 
200 °C immediately adjacent to the antenna was confirmed by the solder experiments. 
This result suggests that peak temperatures on the order of 240 °C (as seen in our 
simulations) may not be unreasonable. While we believe such high temperatures may 
not be unreasonable, more accurate temperature measurements in proximity to the 
ablation device need to be performed to increase simulation accuracy. 
Table 3.3 provides a list of experimentally measured dielectric properties at 915 
MHz and 2.45 GHz in different regions of the ablation zone. Previous studies have 
made similar measurements on liver tissue 2.45 GHz (necrotic, cirrhotic, and 
malignant liver samples), however, the variation of dielectric measurements across the 
regions of the ablation zones are not captured at 2.45 GHz 
35, 36
. From Table 3.3, the 
general trend of the measured electrical conductivity and permittivity decreasing as the 
point of measurement gets closer to the applicator axis is in agreement with their 
study. Similar to the measurements made by Lopresto et al.
18
, our data shows a 
decrease of both relative permittivity and electric conductivity in regions in which the 
temperature increased to over 60 °C (pink and brown region), with a dramatic drop 
within regions that  reached temperatures exceeding 100 °C (char region). This trend 
captured is also in agreement with measurements reported in a pilot study by Brac. in 
the same frequency range
37
. In that study the measured electrical conductivity of 
regions close to the applicator (char region) approaches 0 S/m, and this is reflected in 
Table 3.3 for both frequencies
37
. Although more data is needed to accurately model 
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these types of biophysical tissue changes during MWA, the data presented can better 
inform ablation simulations in this context.  
The fall-off of the electric field and heat deposition with radial distance from the 
applicator feedpoint is shown in Fig. 3.6. This figure shows that over 90% of the 
power is deposited within 2 mm of the applicator
38,39
. Moreover, Figure 3.6 illustrates 
that there is a change in the electric field and heat deposition patterns.   Initially, there 
is deeper electric field penetration at later time points during the ablation at 1-2 mm 
radially from the antenna. However, this pattern changes beyond 2 mm depicting that 
electric field penetrates tissue deeper at the onset of the ablation.  
Using our expressions for the electrical properties of liver and the parts of the 
applicator, we find that a 20% change in the electrical conductivity of liver causes 
only a 5% change in the diameter of an ablation.  This may be understood because, 
while (1) increasing the electrical conductivity σ reduces the electric field within the 
tissue, (2) the power dissipated per unit volume is proportional to σ multiplied by the 
square of the electric field, so these two effects may partially cancel. 
The two plots in Figure 3.7 show the temperature distribution in simulations of 
60 W 15 minute in vivo ablations using Person’s ST applicator with dynamic 
temperature dependence of all properties, and the static properties at 37 °C. The 
transverse ablation diameter estimates are similar in both graphs, however the axial 
ablation diameter for the static property case is larger than the dynamic property 
simulation.  This indicates modeling MWA treatments within liver tissue is very 
sensitive to the dynamic nature of dielectric properties during these procedures. Note 
that the static property model produces ablation extent estimations within 1/10
th
 of the 
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time scale of models that incorporate dynamic properties (4 minutes compared to 40 
minutes respectively), but provides an erroneous pattern by neglecting the dynamic 
effects of the multiphysics. In developing a modeling platform that is clinically useful 
several factors must be considered including model accuracy and solution time. 
Although computational models afford the flexibility for of introducing many levels of 
dynamic intricacy, a balance between model complexity, accuracy, and required 
computational resources must be struck for practical clinical application.  
Biophysical models of tissue heating have been extensively employed for 
guiding the design and optimization of thermal ablation devices and treatment 
parameters (e.g. applied power levels, treatment time, single vs. multiple applicators) 
40
. Although the literature offers some approaches for ablation modeling, most of these 
methods are for ablation modalities such as RFA, laser, etc.  Fuentes et al. used FEM 
with medical imaging datasets to compute current density and transient temperature 
profiles for RFA planning
41
. Several platforms have been proposed for device 
evaluation and predictive planning MWA procedures 
42, 43
. For example, Zhai et al. 
proposed a platform for preoperative surgery planning for percutaneous hepatic MWA 
in which they used iterative framework for necrosis field simulation and 3D necrosis 
zone reconstruction
43
. Nevertheless, these systems were focused on pre-operative 
planning of MWA procedure at 2450 MHz.  The current literature does not provide 
enough data for accurate modeling at this frequency.  The model discussed in this 
study will provide further insight into the physical and biochemical dynamics of 
ablation treatments, thereby improving device design and predictive planning 
capabilities for 915 MHz MWA systems. 
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Conclusion 
The objective of this study was to formulate, develop, and experimentally verify 
a computational modeling platform for simulating MWA with the 915 MHz Perseon 
ST applicator. In summary, the model’s accuracy was confirmed by showing the 
agreement between simulated and measured ablation extents and radial temperature 
slope for  60 W and 30 W. Therefore, the dielectric and thermal liver tissue 
parameterizations used in this study may be good approximations for modeling the 
dynamic changes that occur during MWA at 915 MHz.  Furthermore, the reported 
variation of dielectric measurements across the regions of the ablation zones will lead 
to more accurate parameterization of tissue dynamics to inform MWA simulations. 
Overall, the results of this study will lead to a better understanding of the dynamics of 
ablation, especially in the context of 915 MHz clinical systems. 
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Introduction 
Thermal ablation has emerged as a minimally invasive modality for treatment of 
tumors in the liver, lung, kidney, bone and other organs. Ablation is also in clinical use 
for treatment of malignant and benign disease in prostate and uterine tissue, and for 
treatment of cardiac arrhythmias
1
. Typically, treatments involve the clinician 
percutaneously inserting an ablation applicator during surgery into the region of 
interest, and applying energy to this region to induce necrosis. Ablation may also be 
performed laparoscopically or under open surgery. The most frequently used energy 
sources for thermal ablation include radiofrequency current or microwaves, lasers, 
focused ultrasound, and cooled, thermally conductive applicators with RF and MW as 
the dominant tumor ablation modalities
2,3
. Microwave ablation (MWA) procedures 
have played an increasingly important role in cancer treatment for patients not eligible 
for chemotherapy, radiotherapy or surgical resection. Compared to other ablation 
modalities, advantages of microwave energy include: the potential to produce faster 
heating over a larger volume of tissue even in the presence of heat sinks; effectiveness 
in tissues with relatively high electrical impedance such as lung or charred tissue; 
effective utilization of multiple applicators; and treatments that do not require 
ancillary components
4
. MWA procedures are typically performed with image 
guidance to help localize the disease, inform device placement, and facilitate post-
ablation confirmation of the treated zone. Ultrasound and X-ray computed tomography 
(CT) are the most commonly used imaging modalities for guiding ablation procedures. 
Image-guided ablation treatments have been shown to have relatively low 
complication rates compared to surgical resection
5
. This makes ablation therapy a 
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preferred treatment for high-risk patient populations that are not ideal candidates for 
other more physically taxing and invasive procedures
5,6
. The attempted clinical goal 
for most MWA procedures is to ablate the entire tumor with an additional 5-10 mm 
margin along the entire circumference of the tumor to account for any residual 
cancerous cells that cannot be detected via imaging
7,8
. 
Ablation volume and tumor size are important factors that have been shown to 
correlate with adequate, local control
9,10
. Residual disease left behind after 
percutaneous ablation treatment may be due to the result of failing to achieve a lethal 
thermal dose throughout the target volume
11,12
.  Moreover, such residual disease may 
be exacerbated by remnant tumor potentiating effects
13,14,15
.  The number of variables 
that affect the size and shape of the ablation zone relative to the tumor present a major 
challenge in accurately predicting the ablation treatment zone margin.  For small 
tumors (less than 2 cm diameter) it is likely that complete ablation will be achieved.  
However, for larger tumors ablation zone outcomes have a higher local failure rate
16
. 
Consequently, it has been hypothesized that poor outcomes are due to inadequate 
heating throughout the target volume and that larger tumors may be biologically more 
likely to have spread systemically
17,18
.  Currently, planning for MWA is done with 
vendor specification diagrams that provide estimates of expected ablation treatment 
region size as derived from experimental measurements in non-perfused animal tissue. 
This approach ignores the effects of tissue perfusion, tumor type and location, and the 
influence of surrounding anatomy present in actual clinical procedures. Furthermore, 
the use of 2D ablation zone predictions on 3D anatomy places a considerable burden 
on the physician’s spatial treatment planning skill, and treatment accuracy may be 
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skewed by physician experience. Predictive patient-specific planning and visualization 
tools derived from imaging data, similar to the tools used for guiding delivery of 
ionizing radiation as a cancer treatment, have the potential to improve the reliability of 
thermal ablation procedures.  
Biophysical models of tissue heating have been extensively employed for 
guiding the design and optimization of thermal ablation devices and treatment 
parameters (e.g. applied power levels, treatment time, single vs. multiple 
applicators
)19
. These modeling approaches have been extended and adapted for 
planning ablation procedures. Fuentes et al. used finite element models (FEM) 
informed by magnetic resonance imaging (MRI) datasets to compute current density 
and transient temperature profiles for radiofrequency ablation (RFA) planning
20
. Their 
study used a range of physically realistic blood perfusion parameters in a computer 
simulation to predict ablation lesions measured in vitro in perfused bovine liver 
models. Zhai et al. proposed a platform for preoperative surgery planning for 
percutaneous hepatic MWA that uses an iterative framework for necrosis field 
simulation and 3D necrosis zone reconstruction
21
.
 
 Challenges with the use of 
biophysical models for treatment planning include lack of knowledge of patient-
specific tissue biophysical properties and clinical impracticality due to computational 
time constraints. 
Imaging data that is collected prior to and during ablation treatments has strong 
potential to inform biophysical models for treatment planning. Computational models 
guided by imaging data offer the ability to determine the impact of tissue 
heterogeneity, blood perfusion, antenna positioning relative to the target, vascular 
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cooling, and other parameters that can affect the size and shape of the treatment effect 
region. Specifically, segmented imaging datasets may be used to inform the 
assignment of tissue material properties for computational models. Past studies have 
demonstrated the viability of estimating dielectric properties for radiofrequency 
hyperthermia treatment planning based on CT and MRI data
22,23
. Functional dynamic 
perfusion measurements via CT or MRI have been presented and used by groups for 
the diagnosis and treatment efficacy of liver cancer
24,25
. Anatomical image datasets 
annotated with such biothermal properties could provide more accurate insight into 
ablation margin assessment prior to treatment
26
.  
While computational models can afford the flexibility for including detailed 
tissue anatomy and heterogeneity, a balance between model complexity, accuracy, and 
required computational resources must be struck for practical clinical application. 
Investigating the contributing factors to ablation variance is therefore important 
because they provide guidelines for the level of detail needed for patient-specific 
modeling of microwave ablation procedures. Other groups have investigated the 
effects of changes in tissue properties on tumor ablation zones, however these 
sensitivity studies focused on RFA and did not discuss other possible clinical sources 
of variability
27,28,29
. This paper focuses on measuring MWA variability related to: (1) 
tumor vs. normal tissue heterogeneity, (2) applicator tip position relative to tumor, and 
(3) discrete vessel cooling.  The results of this study identify the tissue biophysical 
properties that have the greatest impact on predicted ablation zone outcome.  
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Methods  
Our approach was to simulate electromagnetic energy deposition and bioheat 
transfer during MWA using a two-compartment model that mimics a tumor embedded 
within background liver tissue.  Varying tissue properties were assigned to each 
compartment to assess the impact of anatomic heterogeneity on treatment outcome. 
Input parameters for the dielectric and thermal properties considered in this study were 
based on previously reported measurements for healthy and malignant (primary and/or 
metastatic) liver tissue. 
Figure 4.1 shows the geometry of the multi-compartmental model for these 
simulations.  Compartment 1 (C1) represents liver and compartment 2 (C2) represents 
a primary hepatocellular carcinoma (HCC) tumor sample embedded within C1.  The 
antenna modeled in this study was the 915 MHz Short-Tip (ST) applicator from 
Perseon Medical (Salt Lake City, UT). Figure 4.1 does not illustrate the modeled 
antenna, and we cannot provide detailed information regarding the antenna geometry 
due to a non-disclosure agreement with Perseon Medical. To allow for reproducibility 
we conducted an additional set of simulations using an insulated 915 MHz dipole 
antenna. These simulations employed the same parameter variance that will be 
discussed later in detail. The geometry of the dipole antenna as well as simulation 
results are reported as additional supplementary data for this study
73
. 
Two tumor sizes were simulated, one with 1.5 cm radius, which is representative 
of the average sized tumors treated for single-antenna cases in our clinic, and one with 
1.0 cm radius to study the effect of smaller tumor size on treatment zone. Typically, 
viability for single-antenna treatment is determined based on the intended ablation 
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margin desired by the clinician, and for most cases a 10 mm circumferential margin is 
ideal. For both tumors, the simulated treatment time was 15 minutes with 60 W of 
power at the generator. Due to attenuation within the power cable, the average power 
at the applicator feed point was approximately 70% of the power at the generator. This 
was accounted for in all simulations. The generator power, treatment duration, and 
tumor sizes were chosen based on review of 10 single-antenna MWA treatments 
performed using the Perseon device at our institution. 
   
Figure 4.1: Two-compartmental geometry with (A) 2 cm length x 1.5 cm width and 
(B) 1.5 cm length x 1 cm width   
Biophysical Model of Microwave Ablation 
The dominant physical processes during microwave ablation are the electric 
fields radiated into tissue by the applicator, absorption of the electric field leading to 
heating, and distribution of thermal energy by thermal conduction and blood 
perfusion
30,31
. Biophysical models of MWA aim to simulate these processes with the 
objective of predicting the transient temperature profile during a procedure. The 
electric fields radiated into tissue by a particular antenna may be approximated with 
analytical expressions, estimated from experimental measurements, or computed 
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numerically. In this study, the radiated electric field was computed with the Helmholtz 
electromagnetic equation (Equation 4.1): 
      
           
     
  
   
           (4.1) 
Where E [V m
-1
] is generated electric field, k0 [m
-1
] is propagation constant in free 
space, μr is the relative permeability ratio, εr is the relative permittivity ratio, σ [S m
-1
] 
is the electrical conductivity, ε0 is the permittivity of free-space, and ω is the 
frequency [rad s
-1
]. Transient temperature profiles in tissue were computed using the 
Pennes bio-heat transfer equation (Equation 4.2
)32,33
: 
  
  
  
                            (4.2) 
where ρ [kg m−3] is tissue density, c [J kg−1 K−1] is tissue specific heat capacity, T[K] 
is temperature, k [W m
−1
 K
−1
] is tissue thermal conductivity, Qmv [W m
−3
] is 
microwave power deposited, mbl [kg m
−3
 s
−1
] is blood mass perfusion rate, cbl [J kg
−1
 
K
−1
] is specific heat capacity of blood and Tbl [K] is temperature of inflowing arterial 
blood.  For MWA sources, the electromagnetic power loss within tissue is given by 
(Equation 4.3
)34
: 
    
 
 
        (4.3) 
Table 1 provides a compiled list of the variables used in these equations along with 
liver nominal values (at 37 °C).  The temperature dependence of tissue properties used 
in our simulation is described in the following sections. 
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Table 4.1. Physical parameters of liver and their nominal values( at 37 °C) used in 
biothermal computational models 
        Parameter Nominal Values Units  
Electrical Properties   
  Relative permittivity, εr 49.03
 
1 
29 
  Electrical conductivity, σ 0.86 S m-1 29 
Thermal properties    
  Thermal conductivity, k 0.51
 
W m
-1
 K
-1
 
32-35 
  Specific heat capacity, cp 3400
 
J kg
-1
 K
-1
 
36 
  Density, ρ 1050 kg m-3 50 
  Nominal blood perfusion rate, mbl 18
 
kg m
-3
 s
-1
 
44,45 
 
The FEM model was implemented in COMSOL Multiphysics v4.4 (Burlington, 
MA) and all post-processing was performed with MATLAB (The Mathworks, Inc., 
Natick, MA). Initial tissue temperature for all models was 37 °C (Tbl). Boundary 
conditions on the edges of the modeled tissue (12 cm × 10 cm ) were set to a fixed 
temperature 37 °C  respectively.  A fixed temperature boundary condition (T = 20 °C), 
was applied at the inner applicator wall to simulate the room-temperature saline 
circulating through the applicator. A high resolution triangular Lagrangian element 
mesh was used throughout all simulation regions, including the boundaries of the 
tumor, applicator, and surrounding liver to discretize the solution space. Specifically, 
the mesh resolution had a maximum element edge length of 0.0024 mm and minimum 
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element size of 4.8 μm.  An implicit solver with a maximum time step of 5 s (0.001 < 
∆ t < 5 s)  was used to solve the transient bioheat equation for 15 min ablations 34. 
Spatial temperature profiles were used to update values of tissue physical properties at 
each time step, as described in the following sections. It is important to note that 
model accuracy was assessed by comparing the simulated ablation zone extents within 
ex vivo tissue to standards provided by the vendor 
35
. 
Table 2 describes the temperature dependent dielectric properties used in our 
simulations. While it is known that tissue dielectric properties change substantially 
during heating to ablative temperatures, detailed measurements of dielectric properties 
at 915 MHz for temperatures above 60 °C are not currently available in the 
literature
36
. In contrast to this, temperature dependent dielectric properties of tissue at 
2.45 GHz have been reported by multiple groups
32,37
. The simplified expressions listed 
in Table 4.2 were obtained by fitting linear equations to experimental data reported in 
a pilot study by Brace
36
. 
Table 4.2. Liver dielectric property parameterization used in models 
          εr (T)         σ (T)                              T (°C ) 
   
                                                 0-95 
                                           95-100 
          30          0.82                                         >100 
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For thermal conductivity, a linear approximation was used (Equation 4.3) where 
k0 is the thermal conductivity at the reference temperature, k1 is a temperature 
coefficient, and T and T0 are the transient and reference temperatures
38,39
. 
Determination of k0 (.503 W m
-1
 K
-1
) and k1 (.092 %°C
-1
) was based on experimental 
data previously reported for experiments performed on human and porcine liver
40,41
. 
Temperature dependent specific heat capacity of tissue was implemented using the 
parameterization reported by Yang et al. 
42
.
 
The steep drop at temperatures above 90 
°C corresponds to the loss of tissue water. 
 
                                   °  
                               ° 
  (4.3)  
The simulated blood perfusion parameterization is outlined in equation 4. This 
expression indicates that below 60 °C the perfusion rate is mbl (kg/m
3
/s), and 0 at 
higher temperatures.  Another method for modeling perfusion within liver is 
simulating this process as a function of thermal dose/damage
 43
. Nevertheless, the 
parameterization described in equation 4.4 (perfusion as a step function of 
temperature, with a 60 °C threshold for the transition) has been used by several groups 
to simulate perfusion during MWA
44,45
.  
  
  
  
                         )  (4.4)  
              
                     
                       
      
Two Compartmental Model 
Stauffer et al. measured the dielectric properties of malignant and normal ex vivo 
human liver tissue
46
. They reported that, on average, the relative permittivity of freshly 
excised human liver tumor at 915 MHz was 12% higher when compared to normal 
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liver and that electrical conductivity was 24% higher than normal liver tissue
46
. A 
study performed by O’Rourke et al. reported that relative permittivity of tumor can 
have mean values of 7% higher than normal  with the largest statistically relevant 
difference being 19% at 915 MHz (one standard deviation away from the mean 
between normal and malignant
)47. O’Rourke et al. also reported that tumor electrical 
conductivity was 16% higher than normal liver on average with the largest statistically 
relevant difference being 44% higher (one standard deviation away from the mean 
from normal and malignant) at 915 MHz
47
.  We compared the largest difference 
between tumor and normal tissue within one standard deviation for the dielectric 
properties. As such, when comparing dielectric property variations, C2 (HCC tumor) 
was assigned a 19% higher permittivity and a 44% higher electrical conductivity than 
the surrounding normal liver (C1). 
Studies have reported thermal conductivity values of core and peripheral tumors 
resected from humans and animal models to be as much as 20% higher than healthy 
liver tissue
48,49,50
. Moreover, it has been reported that patients with hepatic steatosis 
(fatty liver disease) have approximately 50% lower thermal conductivity when 
compared to healthy liver
29
. Considering both situations is important because it is 
becoming increasingly common that patients with colon liver metastatic disease also 
have fatty liver disease secondary to systemic chemotherapy administration
51
. As 
such, this study includes simulating scenarios of fatty liver disease and evaluates its 
clinical relevance in planning MWA procedures for this patient population. To 
consider the variance in these conditions we performed one simulation in which C2 
had 20% higher thermal conductance than healthy liver, and another simulation in 
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which C2 remained 20% higher, but C1 had 50% lower thermal conductance than 
normal healthy liver. 
Previously reported blood perfusion data for cirrhotic, normal and malignant 
liver tissue was used to evaluate the impact that perfusion has on the ablation zone 
treatment effect region.  Previous studies by Zhou et al. and Hashimoto et al. used a 
contrast enhanced triphasic acquisition (arterial, portal venous, and equilibrium phase) 
technique to measure normal hepatic blood flow. In this study normal liver perfusion 
averages of approximately 18 kg/m
3
/s were measured
52,53
. Other studies have reported 
average hepatic blood flow ranges slightly higher and lower (14 kg/m
3
/s - 21 kg/m
3
/s). 
However, the variance in these studies makes it difficult to explore a clinically 
significant range.  In this study we also wanted to simulate cirrhotic liver tissue 
perfusion. A study done by Schutt et al. modeled variation in RFA zone estimates with 
varying perfusion rates using data measured in humans
53
. That data reported cirrhotic 
liver perfusion values to be approximately 36% lower than healthy liver tissue
24
. 
Consequently, 11 kg/m
3
/s was chosen as the cirrhotic liver perfusion parameter.  It is 
important to note that lower perfusion values have been reported for severe cirrhosis 
(e.g. Child-Pugh class C); but these values were not used in this study. Ablation is 
typically contra-indicated for patients with this type of severe cirrhosis since they 
usually undergo transplantation or die of their liver disease, but not of their liver 
cancer
24
. For this set of models, a blood perfusion parameter was added to both C1 and 
C2, with C2 having the tumor perfusion parameter and C1 having either healthy or 
cirrhotic perfusion flow rate. The tumor perfusion input values for C2 included: 3, 7,  
10, 14, 21, and 24 kg/m
3
/s. The hypo-perfused cases were chosen to incorporate the 
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25
th
-75
th
 percentile ranges reported in two previous studies that measured HCC blood 
flow rate
54,55
. The last hyper-perfused tumor case was modeled because several groups 
have reported tumors that had relatively higher hepatic blood flow rates than their 
surrounding parenchyma
56
. To see how the combination of these properties affected 
the ablation zone margin, the largest variance of all properties discussed was modeled 
and compared to the baseline homogeneous healthy liver model.  
Ablation Zone Margin Comparison 
The 52 °C isothermal contour at the end of the 60 W 15 minute simulations for 
all models was used as the comparison metric. In a previous study, the 52 °C 
isothermal contour was in agreement with the Arrhenius thermal damage and 
CEM43=240 thermal dose metrics
57
. Therefore, for this study used the 52 °C as a 
metric for comparing ablation zone boundaries predicted by simulations.  Figure 4.2 
illustrates the comparisons that are made for each of the simulations discussed.  
 
Figure 4.2: Illustration of the isothermal comparisons made in this study. For each 
simulation, the 52 °C isotherm contour lines were evaluated to make transverse and 
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radial axis measurements and volume comparisons between tumor electrical and 
thermal property variance simulations.  
 
Applicator Position  
Ablation treatments are typically performed under image guidance, which allows 
the clinician to deliver treatments more precisely. Although treatment accuracy is 
improved using medical imaging, challenges such as guiding the applicator through 
surrounding anatomy (e.g. rib cage and large blood vessels) coincident with patient 
respiratory motion can lead to imprecise positioning.  A clinical study done by Zhang 
et al. showed significant asymmetry in the ablation zone as a result of shifts in RFA 
needles (approximately 2-5 cm
)58
. A translatable analysis of applicator placement in 
the context of MWA would provide more insight into their impact on MWA 
outcomes. Therefore, to evaluate the sensitivity of MWA antenna position we 
simulated all tumor perfusion models previously discussed with the antenna moved 5 
mm anteriorly (+5 mm) and posteriorly (-5 mm). Comparisons of the reference 
position ablation margin and thermal profile were made to these antenna displacement 
simulations. 
Large Vessel Cooling 
The liver is an intricately perfused organ that circulates blood from the hepatic 
artery and the portal vein. Portal and hepatic veins of different sizes are found 
throughout the liver. Several studies have shown that during thermal ablation, large 
blood vessels may induce considerable tissue cooling and thereby limit the size of the 
coagulation zone
59,60,61
. To investigate the impact of discrete vessels adjacent to the 
desired target, we considered variably sized blood vessels positioned at varying 
distances from the tumor. Since this study employed axially symmetric mode 
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geometry, incorporating a circular cross-section vessel would correspond to a “donut 
shaped” vessel in 3D, i.e. a vessel encircling the tumor and applicator. Although such 
a vessel is physically unrealistic, it affords comparative evaluation of the heat sink 
offered by vessels placed at varying distances from the target volume. The heat-sink 
offered by the discrete vessels was modeled using a convective heat flux boundary 
condition as in a study done by Haemmerich et al.
62
.  Equation 4.5 shows the 
convective cooling boundary conditional parameterization used for these simulations, 
where   is the heat transfer coefficient,     is the Nusselt number that is proportional 
to vessel length and flow rate, and   is vessel diameter. A previous study used a 
similar boundary condition for vessel sizes between 3 mm and 18 mm.  Each vessel 
was simulated to have a vessel wall thickness of 1 mm and length of 70 mm, the 
typical length of the portal vein
63
.    
            (4.5) 
Blood vessels of 7 mm, 10 mm, and 15 mm  diameter were simulated at distances of 2 
mm, 5 mm and 10 mm from the tumor.  The agreement between the simulated 
baseline (S) and vessel-cooled (S with boundary volume, SBV) treatment effect regions 
is summarized with a Dice coefficient (Equation 4.6). 
              
         
         
             (4.6) 
This comparison was performed for multiple simulations using models with normal 
and HCC blood flow rates with and without with a nearby vessel. 
Results 
Initial model accuracy was assessed by comparing the simulated ablation zone 
extents to the vendor provided ablation size guidelines.  Results from experiments in 
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ex vivo tissue provided by the vendor indicated ablation zone dimensions of 2.6 cm x 
3.2 cm for 60 W, 5 min, and 3.1 cm x 3.7 cm for 60 W, 10 min; simulations run 
mimicking these experimental conditions yielded ablation zone dimensions of 2.70 cm 
x 3.50 cm, and 3.5 cm x 4.2 cm, respectively
35
. The final ablation zones for the two-
compartmental simulations are summarized in Table 4.3 and Table 4.4.  Table 4.3 
shows the results of the two-compartmental model simulating the 1.5 cm length x 1.0 
cm width tumor (C2) within surrounding normal liver tissue (C1). Table 4.4 shows the 
results of the two-compartmental model simulating the 2.0 cm length x 1.5 cm width 
tumor (C2) within surrounding normal liver tissue (C1). The dielectric and thermal 
property variations and their subsequent transverse and axial ablation diameter 
measurements of the ablation treatment effect region are shown.  In addition, the 
tables show the total volume for each ablation simulation (as implied by radial 
symmetry), as well as a volumetric comparison (percent difference) to an ablation 
simulated in a normal homogenous liver. Table 4.5 shows a comparison of MWA zone 
variance across normal liver perfusion range.  Figure 4.3 shows the final ablation zone 
dimension from a two-compartmental model that simulates the worst-case 
combination across the values studied for all parameters in both tumor sizes. 
Comparison of the transverse and axial ablation zone diameters for all of the 2.0 cm x 
1.5 cm perfusion variance simulation was performed with the antenna shifted 5 mm 
anteriorly and posteriorly respectively. The results of this antenna placement 
sensitivity analysis showed that there was less than a 1.5 mm radial difference in the 
size of the ablation zone as a result of this shift. Figure 4.4 shows the change in 
clinical ablation margin after displacing the antenna 5mm anteriorly (A) and 
 74 
 
posteriorly (B) from the 2.0 cm x 1.5 cm tumor. The next set of simulations modeled 
the change in ablation zone dimension due to hepatic vessels near the region of 
interest. Three blood vessel diameters were simulated (7 mm, 10 mm, 15 mm) at 2 
mm, 5 mm, and 10 mm distances from the tumor edge.  Figure 4.5 shows the results of 
the 15 mm diameter blood vessel at those distances. Table 4.6 shows the Dice 
coefficient comparison of ablation zone extents for all blood vessel simulations.  
Table 4.3: Compiled variances from the two-compartmental simulations for 1.5 cm 
x1.0 cm tumor. * C1 for model had a multiplier of 0.5 to simulate tumor within 
surrounding fatty liver 
Liver 
Tissue 
(C1) 
Changed 
Parameter 
Tumor(C2) 
Parameter 
Multiplier 
Axial  
diameter (cm)  
[% Diff.] 
Transverse 
diameter (cm) 
[%Diff.]  
 
Volume 
(cm
3
) 
[%Diff.] 
 
Normal No Change No Tumor, 
Homogeneous 
(i.e C1=C2) 
3.52 2.98 9.75   
 Electrical        
Normal εr (T), σ (T) (1.19,1.44)    3.43 [-2.30%]      3.00 [+0.67%]    9.65 [-1.03%]   
 Thermal        
Normal k (T) (1.20)     3.52 [0%]      2.97 [-0.34%] 9.78[ +0.31%]   
Fatty*    
Liver 
k (T) (1.20)     4.02 [+13.30%]      3.18 [+6.49%] 12.78 [26.90%]   
 Perfusion        
_____________________________________________________________________________________________ 
Cirrhotic 11(kg/m3/s) No Tumor, 
Homogeneous 
(i.e C1=C2) 
    3.89 [+9.99%]      3.38 [+12.58%] 14.15 [+36.79%] 
 
 
Normal 18 (kg/m3/s) 3   (kg/m3/s)     3.41 [-3.17%]      2.97 [-0.34%] 9.76 [+0.11%]   
Cirrhotic 11 (kg/m3/s) 3   (kg/m3/s)     3.88 [+9.73%]      3.37 [+12.28%] 14.05 [+36.13%]   
Normal 18 (kg/m3/s) 7   (kg/m3/s)     3.51 [-0.28%]      2.97 [-0.34%] 9.76 [+0.11%]   
Cirrhotic 11 (kg/m3/s) 7   (kg/m3/s)     3.89 [+9.99%]      3.37 [12.28%] 14.05 [+36.13%]   
Normal 18 (kg/m3/s) 10 (kg/m3/s)     3.51 [-0.28%]      2.97 [-0.34%] 9.74 [-0.12%]   
Cirrhotic 11 (kg/m3/s) 10 (kg/m3/s)     3.89 [9.99%]      3.38 [15.58%] 14.10 [+36.50%]   
Normal 18 (kg/m3/s) 14 (kg/m3/s)     3.52 [0%]      2.98 [0%] 9.91 [+1.60%]   
Cirrhotic 11 (kg/m3/s) 14 (kg/m3/s)     3.89 [+9.99%]      3.40 [+13.17%] 14.35 [+38.16%]   
Normal 18 (kg/m3/s) 21(kg/m3/s)     3.52 [0%]      2.98 [0%] 9.91 [+1.60%]   
Cirrhotic 11 (kg/m3/s) 21(kg/m3/s)     3.88 [+9.73%]      3.38 [+12.32%] 14.05 [+36.13%]   
Normal 18 (kg/m3/s) 24 (kg/m3/s)     3.51 [-0.28%]      2.77 [-7.30%] 4.91 [+1.60%]   
Cirrhotic 11 (kg/m3/s) 24 (kg/m3/s)     3.89 [+9.99%]      3.38 [+12.58%] 14.10 [36.50%]   
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Table 4.4: Compiled variances from the two-compartmental simulations for 2.0 cm 
x1.5 cm tumor. * C1 for model had a multiplier of 0.5 to simulate tumor within 
surrounding fatty liver 
 
Liver 
Tissue 
(C1) 
Changed 
Parameter 
Tumor(C2) 
Parameter 
Multiplier 
Axial  
diameter (cm)  
[% Diff.] 
Transverse 
diameter (cm) 
[%Diff.] 
 
Volume 
(cm
3
) 
[%Diff.] 
 
Normal No Change No tumor, 
Homogenous 
(i.e. C1=C2) 
3.52 2.98 9.75   
 Electrical        
Normal εr (T), σ (T) (1.19,1.44)      3.43 [-2.59%] 3.04 [+1.99%] 10.08 [+3.33%]    
 Thermal        
Normal k (T) (1.20)      3.50 [-0.57%] 2.98 [0%] 9.66 [-0.93%]   
Fatty* 
Liver 
k (T) (1.20)   3.99 [+12.52%] 3.19 [+6.81%] 12.95 [+28.19%]   
 Perfusion        
_____________________________________________________________________________________________ 
Cirrhotic 11(kg/m3/s) No Tumor, 
Homogenous 
(i.e. C1=C2) 
3.89 [+9.99%] 3.38 [+12.58%]   14.15 [+36.82%] 
 
 
Normal 18 (kg/m3/s) 3   (kg/m3/s) 3.51 [-0.28%] 2.97 [-0.34%]  9.71 [-0.41%]   
Cirrhotic 11 (kg/m3/s) 3   (kg/m3/s)  3.88 [+9.73%] 3.37 [+12.28%]  14.09 [+36.41%]   
Normal 18 (kg/m3/s) 7   (kg/m3/s) 3.51 [-0.28%] 2.97 [-0.34%]  9.71 [-0.41%]   
Cirrhotic 11 (kg/m3/s) 7   (kg/m3/s)  3.86 [+9.21%] 3.38 [+12.58%]   14.09 [+36.41%]   
Normal 18 (kg/m3/s) 10 (kg/m3/s)     3.52 [0%] 2.95 [-1.01%]   9.70 [-0.51%]   
Cirrhotic 11 (kg/m3/s) 10 (kg/m3/s)   3.88 [+9.73%] 3.37 [+12.28%]    14.09 [+36.41%]   
Normal 18 (kg/m3/s) 14 (kg/m3/s) 3.51 [-0.28%] 2.97 [-0.34%]   9.72 [-0.31%]   
Cirrhotic 11 (kg/m3/s) 14 (kg/m3/s)  3.88 [+9.73%] 3.37 [+12.28%]     14.05 [+36.31%]   
Normal 18 (kg/m3/s) 21 (kg/m3/s) 3.51 [-0.28%] 2.97 [-0.34%]    9.71 [-0.41%]   
Cirrhotic 11 (kg/m3/s) 21 (kg/m3/s)  3.88 [+9.73%] 3.37 [+12.28%]    14.09  [+36.41%]   
Normal 18 (kg/m3/s) 24 (kg/m3/s)     3.52 [0%] 2.97 [-0.34%]    9.71 [-0.41%]   
Cirrhotic 11 (kg/m3/s) 24 (kg/m3/s)     3.88 [9.73%] 3.37 [+12.28%]    14.09 [+36.41%]   
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Table 4.5: Comparison of MWA zone variance across normal liver perfusion range  
Liver perfusion 
(kg/m
3
/s) 
Axial Diameter 
       (cm) 
Transverse Diameter 
(cm) 
 Volume 
(cm
3
) 
14 3.73 3.13  11.74 
16 3.63 3.02  10.72 
18 3.52 2.98  9.75 
21 3.43 2.79  8.53 
 
 
Figure 4.3: Isothermal comparison of the ablation zone for each tumor size model.  
The dashed lines represent the simulated ablation zone size when each tumor size had 
the worst-case combination of studied variability across physical parameters.  
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Figure 4.4: The change in ablation margin after displacing the antenna 5mm anteriorly 
(A) and posteriorly (B) 
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Figure 4.5: Simulation of vessel cooling by 15mm diameter blood vessel and its 
impact on the ablation zone.  The  baseline simulation without a vessel (A) was 
compared to simulated vessels a distance of 2mm (B), 5mm (C), and 10mm (D) away 
from the edge of the tumor and had a connective cooling condition that was 
proportional to the length and diameter of the vessel.  
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Table: 4.6: Dice coefficient values for comparing ablation zone extents for all blood 
vessel simulations. The dice coefficient was evaluated by comparing the size of the 
ablation zone from all liver models containing a vessel with normal and HCC blood 
flow rates to a baseline simulation without a blood vessel   
 
Vessel Diameter 
     (mm) 
Vessel Distance  
       (mm) 
Qs 
(Normal Flow) 
Qs 
(HCC Flow) 
    
        7           2 0.936 0.935 
       10           2 0.917 0.918 
       15           2 0.891 0.891 
        7           5 0.950 0.950 
       10           5 0.938 0.938 
       15           5 0.921 0.921 
        7              10 0.998 0.998 
       10          10 0.998 0.998 
       15          10 0.990 0.990 
    
 
Figure 4.6: Ablation zone comparison of ablation when simulating a 7mm, 10mm, and 
15mm vessel at a distance of 2cm from the tumor.  The desired clinical ablation 
margin is shown to compare the impact of the simulated vessel cooling.  
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Discussion 
Table 4.33 and 4.4 show the results of the two compartmental modeling 
experiments with varying dielectric properties and thermal properties for each of the 
two tumor sizes discussed.  When incorporating the coupled difference in relative 
permittivity and electrical conductivity between malignant and healthy liver tissue, 
these simulations showed slight variations in the axial or transverse diameter (less than 
6 mm) in ablation zone size.  In addition, the smaller ablation zone volume as a result 
of the higher tumor permittivity relative to background liver tissue is reflective of 
shallower microwave penetration
6
.  However, this effect is less prominent when 
simulating heterogeneity for the larger tumor model. Moreover, higher electrical 
conductivity of the tumor relative to the background liver tissue may have enhanced 
heating in a small margin surrounding the tumor as reported by Sollazo et al.
64
. The 
slight decrease in volume due to the dielectric heterogeneity for the smaller simulated 
tumor  (approximately 0.10 cm
3
) when compared to the homogeneous liver simulation 
reflects this result.  However, it is not well understood whether this observation has 
relevant clinical impact.  The results of our study provide insight into accounting for 
dielectric properties when modeling MWA procedures in liver. The results suggest 
that when using this antenna and power/time combination, treatment outcome is 
minimally impacted by dielectric heterogeneity in tumor or healthy tissue.  Similarly, 
varying tumor size resulted in less than 4% volume difference across these scenarios.  
These results are important in anticipating patient-specific treatment modeling, in 
 81 
 
which adequate modeling of heterogeneity must be weighed against increasing 
computational complexity and clinical time. 
The variance of thermal conductivity showed a more clinically relevant impact, 
with a 27% increase in volume (more than 3 cm
3
) between simulated treatment effect 
regions in livers with fatty liver disease versus the baseline homogeneous normal liver 
simulation. This result suggests that it will be useful to identify specific kinds/stages 
of liver diseases (including fatty liver) when modeling patient-specific ablation 
treatment effect regions.  This result is in agreement with Brace et al. which has 
explained that increases in thermal conductivity allow for potential increases in 
ablation margins
6
. 
The impact of hepatic perfusion variance on ablation outcomes has been 
extensively discussed in the literature.  In this study, we simulated several hypo-
perfused and hyper-perfused tumors within normal and cirrhotic liver perfused liver 
and evaluated the resulting ablation zone sizes. The lower perfusion rate of cirrhotic 
tissue is of particular importance for tumor ablation because approximately 90% of 
patients with primary liver cancer (HCC) suffer from cirrhosis 
65
.  Our results suggest 
that ablation zone volume could increase by 36% or more ( > 4 cm
3
) in patients with 
cirrhotic liver tissue surrounding the tumor. Schutt and Haemmerich have similarly 
reported that lower perfusion rates in cirrhotic patients resulted in larger ablation 
zones than in those with normal liver tissue for RFA
24
. Furthermore, the results 
reported in Table 4.5 indicate that there is a significant change in ablation zone extents 
within the normal hepatic perfusion range.  This result also suggests that it will be 
useful to distinguish cirrhotic versus healthy tissue when modeling patient-specific 
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ablation treatment effects. Moreover, the variance effects reported in Table 4.5 
suggests that accurate quantification of hepatic perfusion even among healthy patients  
may be essential for pre-operative planning for MWA. The hyper-perfused and hypo-
perfused tumor simulations within surrounding normal liver tissue showed minimal 
variation in volume (less than 2%) when compared to simulations in which the 
surrounding tissue was cirrhotic.  These results indicate that although perfusion may 
be the most important parameter to incorporate in a patient-specific manner, the 
relative difference in blood perfusion of the tumor itself when compared to 
surrounding tissue may only play a small role in modeling ablation zone outcomes. 
Figure 3 further supports this claim by showing minimal change in ablation zone 
extents when the homogeneous normal liver baseline simulation is compared to a 
simulation of a cirrhotic liver. This model simulated the worst-case combination of 
thermal and electrical properties variations. There are clinical tools and protocols used 
to parameterize perfusion 
22,25,54,55
.  These tools employ techniques, such as correlating 
HU change with volumetric blood flow by measuring the flow of contrast over several 
different arterial and venous liver phases via CT or MR to quantify perfusion for 
diagnosis and possible treatment modalities 
22,25,52,53
.  The discussed results advocate 
using such tools and approaches to quantify perfusion parameters as inputs into patient 
specific modeling strategies. 
It is important to note that these results are reflective only of cases with small 
tumors that can be treated effectively with a single antenna (less than 2 cm diameter).  
In a similar study previously done by our group using a dipole antenna on a larger 
hepatocellular carcinoma, there was substantially more variation in ablation zone size 
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given similar hyper-perfused and hypo-perfused tumor parameters to those used 
here
57
.  This is less clinically relevant for single antenna treatments, but warrants 
further investigation as we anticipate multiple antenna simulations. 
The results of the antenna displacement model scenarios indicate that the 
absolute difference in axial and transverse ablation diameter are insensitive to 
applicator position (< 1.5 mm difference).  However, when considering the overlap 
between the ablation zone and the ideal clinical margin when the antenna was 
displaced 5 mm anteriorly and posteriorly, there was approximately a 6 mm gap 
between the margins as depicted by Figure 4.4.  Additionally, a recent study 
simulating ablation zone variation when multiple antennas were displaced in a non-
parallel fashion showed that this type of perturbation could result in substantial 
differences in power deposition
66
.   This suggests that proper treatment planning 
approaches need to be developed to account for accurate needle placement.   
Table 4.6 shows Dice coefficient measurements for the blood vessel simulations.  
As expected, the 15mm diameter blood vessel showed the largest impact on the 
ablation treatment effect region.  The predicted ablation for the model scenario that 
simulated a 15 mm blood vessel 2 mm away from the tumor was approximately 11% 
smaller than the baseline according to Dice statistics.  This is depicted in Figure 4.5 as 
the ablation zone radius being approximately 5 mm smaller in transverse radius (10 
mm in diameter) when compared to the ablation zone simulation without the blood 
vessel.  The difference in ablation zone extent was 8-9% smaller as the blood vessel 
distance from the tumor increased to 5 mm and 10 mm.   A similar trend was seen in 
the other blood vessel sizes with distance from the tumor. This result is consistent with 
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previously reported data that suggests significant heat-sink effects caused by hepatic 
veins as far as 8 mm away
67
. In relation to blood vessel size, the effect of convective 
cooling by the blood vessel seemed to increase with blood vessel diameter, as 
illustrated by Figure 4.6.  The findings in Lu et al. and Pillai et al. support this claim 
by reporting that heat-sink effect is significantly dependent on hepatic vein size, 
especially when discussing vessels greater than 3 mm in diameter
68,69
.  At a distance of 
10 mm or greater our data suggests that blood vessels less than 10 mm in diameter do 
not cause much variation in the ablation zone outcome .  However, blood vessels 
larger than 10 mm potentially may have an effect on ablation treatment outcomes. 
Typical diameters of the main and first order portal vein and hepatic veins are 0.8 – 27 
mm and 5-15 mm
70
.  Nevertheless, it is rare to encounter a vessel greater than 10 mm 
peripherally. Clinically, it is more common to encounter a vessel diameter of that size 
centrally within the liver. 
The model employed in this study does not account for tissue shrinkage due to 
steam transport which may affect the growth of the ablation zone. Moreover, this 
study estimated the ablation zone with the 52 °C isotherm contour, rather than thermal 
dose or thermal damage. Although cell death due to thermal damage is a complex 
function of the time-temperature history during heating, using an isotherm for 
estimating the extent of the ablation zone is a reasonable approximation when 
comparing ablations over the same treatment duration
57
. In our models, the blood 
perfusion rate is adjusted only as a function of temperature, rather than temperature 
and time.  In addition, although the peak temperatures reported by our simulations 
appear to be high (~240 C), there remains a lack of research showing accurate 
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measurement of peak tissue temperature immediately adjacent to an ablation 
applicator (i.e. these high simulated temperatures can neither be corroborated or 
discredited
)43
. Lastly, all models considered for this variance study apply to smaller 
tumor sizes, thus further investigation may be warranted when considering MWA 
margin variance among larger tumors. 
The objective of this study is to identify what level of heterogeneity needs to be 
captured for ablation modeling for patient-specific applications. The results of the 
simulated scenarios suggest that varying perfusion within the liver (cirrhotic vs 
normal) has significant impact on ablation zone extent variability and should be 
carefully measured and incorporated in patient-specific planning for MWA.   The 
significant variability in ablation extents when comparing simulations of normal liver 
and fatty liver (thermal conductivity variance) also suggests careful quantification for 
patient-specific applications .  Moreover, in the context of MWA margin assessment 
antenna placement and vasculature within the vicinity of 10 mm should also be 
carefully analyzed and incorporated in predictive planning. The results suggest that 
heterogeneity between tumor and surrounding liver dielectric properties (electrical 
conductivity and permittivity) does not provide significant changes during MWA, and 
therefore may be approximated as  homogeneous for patient-specific planning.   
Nevertheless, in order to evaluate the discussed parameters in the context of assigning 
patient-specific values for model improvement, another study is needed to evaluate 
combinatory effects of these parameters. The presented results is a first step towards 
accomplishing this task, but a follow-up study is warranted using statistical techniques 
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for evaluating which biophysical tissue properties cause the most impact on thermal 
margin.  
Nevertheless, in order to evaluate the discussed parameters in the context of 
assigning patient-specific values for model improvement, another study is needed to 
evaluate combinatory effects of these parameters. The presented results is a first step 
towards accomplishing this task, but a follow-up study is warranted using statistical 
techniques for evaluating which biophysical tissue properties cause the most impact on 
thermal margin.  
Future work will concentrate on further evaluation quantification of the ablation 
sensitivity to some of the discussed parameters via CT or MRI within the liver.  
Nevertheless, incorporating these types of imaging quantification techniques in the 
clinical workflow will be difficult, due to the amount of time and necessary steps to 
make precise and accurate measurements.  For example, the presented results indicate 
hepatic perfusion may potentially be an important parameter to incorporate in a 
patient-specific manner; however, commonly used techniques involve measuring the 
flow of contrast over several different arterial and venous liver phases (via CTor 
MRI), which is taxing on the patient, can lead to additional patient radiation dose, and 
can take a considerable amount of time
24,25
. In addition, the results suggest the 
potential need for accurate vessel reconstruction techniques.  There are known 
techniques for accomplishing vascular reconstruction, such as vessel tree segmentation 
71
.  Moreover, this technique has been used with the intent for numerical simulation 
for RFA
72
. 
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Detailed 3D patient-specific segmentation and representative meshing within 
the simulation will most likely be needed in order to more accurately quantify the 
thermal effect. Clinically, attempts at applicator placement confirmation are performed 
via intra-operative imaging right before the procedure begins. However, pre-operative 
positioning errors and intra-operative patient motion increases the uncertainty 
applicator placement, and therefore allows for variation of the intended ablation 
margin. A MWA planning system that can provide an ideal applicator insertion 
position and trajectory while accounting the biophysical inputs and maintaining 
clinical feasibility would be ideal. Such a tool within the planning platform would 
need a highly sophisticated 3D imaging system that could be imported into 
simulations that uses modeling techniques (i.e. Monte Carlo) to generate the most 
likely applicator insertion. 
Conclusion 
The goal of this study was to identify the parameters that can be derived from 
imaging that will have the greatest impact on the shape and size of a MWA treatment 
effect region. The results from simulating treatment effects given variance in tissue 
thermal and electrical properties will help to better approximate MWA zone extents 
using biophysical modeling techniques.  Moreover, these simulations help identify 
properties that we should concentrate on in patient-specific modeling, and which 
properties we can approximate with a certain level of confidence.    Ultimately, this 
study will help understand and effectively predict the underlying bio-physical changes 
that occur over the duration of MWA procedures in order to make a more useful 
treatment planning system. Although, more data needs to be collected in order to 
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develop a clinically useful treatment planning simulation tool, the presented results 
will help in developing a potential platform for incorporating patient specific 
biophysical measurements for simulating MWA procedures.  
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Introduction 
Microwave ablation (MWA) procedures have been playing an increasingly 
important role in the treatment of cancer.  Compared to radiofrequency ablation, 
MWA induces faster heating over a larger volume of tissue, is more effective near 
vasculature, is effective in tissues with relatively high electrical impedance (such as 
lung or charred tissue), has the advantage of  utilization of multiple applicators, and 
does not require ground pads [1].  MWA procedures are typically performed with 
image guidance (X-ray Computed Tomography (CT) or Ultrasound) to help localize 
the disease, inform device placement, and facilitate post-ablation confirmation of the 
treated zone.  Nevertheless, on a patient specific basis, MWA still has many unknowns 
with regard to the energy dissipation from the antenna, as well as biophysical effects 
in tissue adjacent to the antenna and at the treatment margin [2,3].  
Pre-operative patient-specific planning and visualization tools have the potential 
to improve the reliability of MWA procedures as both a palliative and curative 
treatment modality.  Predictive planning is becoming increasingly important for MWA 
procedures as clinicians move toward standardizing surgical approaches.  The 
attempted clinical goal for most MWA procedures is to ablate the entire tumor with an 
additional margin (typically ~ 5-10 mm ) along the target circumference to account for 
any residual cancerous cells that may not be detected via imaging [4,5].  Residual 
disease left behind after treatment may be the result of inadequate ablation margin 
[6,7].   
The current standard for MWA planning is restricted to dimensions of ellipsoids 
parameterized from ex vivo tissue tests, with some new systems providing overlays of 
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these ellipsoids on pre-treatment imaging  [8]. This approach ignores the effects of 
tissue perfusion, tumor type and location, and the influence of surrounding anatomy 
present in actual clinical procedures. Furthermore, the use of 2D ablation zone 
predictions on 3D anatomy places a considerable burden on the physician’s spatial 
treatment planning skill, and treatment accuracy may be skewed by physician 
experience. To facilitate personalized treatment delivery and simplify planning for 
physicians, there has been renewed interest in the development of modeling and 
visualization techniques towards treatment planning of ablation treatments [9,10,11]. 
Mathematical models of the processes that occur during MWA have been 
employed during the design and optimization of devices for MWA [12,13,14,15,16]. 
These models use numerical techniques to solve the partial differential equations 
which govern electromagnetic propagation, power deposition, and bioheat transfer 
[17,18]. Such models may help physicians to choose the treatment parameters (e.g. 
number of antennas, applied power levels, antenna insertion paths) which maximize 
the likelihood of a desired treatment outcome. Predictive modeling tools are of 
particular clinical relevance due to the shortage of practical techniques for intra-
operative monitoring of thermal damage.  There are few proposed simulation 
platforms that have been adapted for planning ablation procedures in the context of 
ablation [10, 11, 19, 20]. Challenges with creating a treatment planning simulating 
framework for MWA include: limited patient-specific knowledge of tissue biophysical 
properties, integrating data from clinical imaging datasets with computational models, 
impracticality of lengthy computational times within the clinical workflow, and lack 
of knowledge of the applicator geometry. 
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Current MWA models often include multi-physics simulation techniques to 
compute the electric field and electromagnetic power absorption profile within tissue. 
Calculation of the electric field radiated by a particular applicator, requires knowledge 
of the antenna geometry, and applicator material properties. Furthermore, accurate 
patient-specific calculations require knowledge of tissue dielectric properties for 
individual patients. However, the proprietary design of applicators in current clinical 
use is usually unknown.  Alternative simulation techniques that characterize the power 
absorption pattern during MWA without requiring knowledge of proprietary antenna 
design information may facilitate bioheat transfer modeling within clinical treatment 
planning. 
 Infrared thermographic SAR measurement, which has been in use for more than 
several decades [21], is well suited to interstitial measurements because of the high 
spatial resolution afforded by commercial thermal cameras, as well as the ability to 
image the temperature distribution of an entire plane in a single experiment.  Some 
work has been done to investigate thermographic SAR measurements and minimizing 
associated measurement error under experimental conditions for external applicators 
[22].  A study involving measuring SAR for interstitial hyperthermia devices using an 
IR thermogaphic system was done by Gladman et al. [23].  They acquired serial 
thermograpahic IR temperature measurements that were made during multiple heating 
periods and cooling periods within a tissue equivalent phantom to determine errors 
caused by thermal conduction and convection when calculating SAR.  In that study the 
phantom was layered so that the interstitial device was not exposed during heating ; 
temperature data acquisition was limited to the period immediately following heating.   
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Another study performed by Haemmerich et al. used thermocouples to acquire 
temperature data in a similar fashion to correct for thermal conduction errors during 
tissue heating [24].  
The goal of the current study was to examine any differences between the SAR 
profile predicted by multi-physics simulations and SAR computed from 
experimentally measured temperature profiles with an infrared camera. This study 
employed commercially available antennas in clinical use (Perseon Medical Short Tip 
and Long Tip antennas) with known geometry. This will serve as experimental 
validation of the multi-physics model, and the experimental SAR data may allow an 
alternate modelling strategy where experimentally measured SAR data are used in a 
computer model to allow simulation of MWA procedures in absence of knowledge of 
the antenna geometry. 
 
 
 
 
 
 
 
Methods   
Experimental Setup 
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We used the experimental setup illustrated in Figure 5.1 to measure SAR in fresh ex 
vivo porcine liver tissue. We performed a total of 9 studies to measure the change in 
SAR during ablation with either of two clinically employed 915 MHz MWA antennas: 
Perseon short-tip (ST) antenna (n=3), or long-tip (LT) antenna (n=6). Liver tissue 
samples were placed in 0.9% saline until tissue temperature was completely 
equilibrated with water bath temperature (21 ºC). The MW antenna was placed in firm 
contact on top of a tissue sample. An infrared camera (Mikron M7500) was positioned 
above the sample and additional thermocouples were placed on the tissue surface to 
calibrate temperature values derived from the IR camera. We assumed tissue 
emissivity of 0.9 [25]. The tissue surface temperature was recorded via IR camera 
(~3.3 fps, 320x240 resolution) and stored on a PC for later image analysis. Microwave 
power (20 W) was applied to the antenna for a total of 6 minutes, and antenna cooling 
by room temperature water was initiated just before power was turned on. Power was 
interrupted for ~5 seconds every 20 seconds (0-2 minutes), or every 30 seconds (2-6 
Figure 5.1. Setup for experimental measurement of SAR. (A) Tissue sample is 
heated with MW antenna and temperature is recorded with infrared (IR) 
camera data and thermocouples. (B) Transient temperature data is analyzed for 
each pixel and (C) SAR calculated. Thermocouples are used to calibrate IR 
camera data temperature. 
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minutes). At the end of each study, a photographic image was taken to visualize the 
coagulation zone. 
The initial rate of temperature rise was calculated for each pixel from the IR 
imaging data (Fig. 1.  B,C). In addition, slope of temperature rise/fall was calculated 
just before, and just after each time power was turned off (t
-
off, t
+
off). Similar to a prior 
study, SAR was calculated during heating from these two slopes [24] as specified in 
equations 1 and 2.  In both equations c is the specific heat of the tissue sample, k is the 
thermal conductivity of the tissue sample, and ρ is the tissue density.  Since the tissue 
temperature is equal immediately before (t
-
off), and immediately after (t
+
off) the power 
is turned off, the heat conduction term (first right-hand term in equations 5.1 and 5.2) 
also has to be identical as it depends on the temperature gradient; however, SAR=0 
right after power is switched off (t
+
off), leaving only the thermal conduction term in 
equation (5.2). 
SAR
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t
T
c
offt
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
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SAR during MW heating can then be calculated by subtraction of equation (5.2) from 
equation (5.1), i.e. by subtraction of the two temperature slopes before and after power 
is turned off (equation 5.3): 
SAR = c
¶T
¶t t
-
off
-
¶T
¶t t
+
off
æ
è
ç
ö
ø
÷ (5.3) 
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Figure 5.2: Example point temperature change at during an ablation experiment in 
which the power was intermittently turned off to correct for thermal conduction. 
 
Thus, we were able to calculate SAR at the beginning of each experiment, as well as 
each time power was transiently turned off, every 20 s (0-2 minutes), or every 30 s (2-
6 minutes) as illustrated in Figure 5.2. 
Data Analysis of Experiments 
Experimental infrared temperature measurements and subsequent transient SAR 
spatial profiles were post processed using MATLAB (The Mathworks, Inc., Natick, 
MA). The spatial temperature changes captured by the infrared camera were compared 
to a previously validated simulation model using the Perseon ST antenna [9] that 
mimicked the same experimental setup (discussed in the next section). The initial and 
transient SAR profiles were compared to the simulation as well. The simulated 
ablation zone and SAR profile (Ssim)  were compared to the  experimentally measured 
ablation zone and SAR profile (Sexp) using  a Dice coefficient (Equation 5.4). 
               
             
             
             (5.4) 
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Simulation Framework 
A 3D model was employed in this study as illustrated in Figure 5.3. The 
simulation geometry illustrated is similar to the experimental setup previously 
discussed in which half of the antenna was immersed within liver tissue sample and 
half was exposed to air. The FEM model was implemented in COMSOL Multiphysics 
v4.4 (Burlington, MA) to simulate the described experiment.  The model used to 
simulate the ablation experiments for this study was used in a previous study to 
quantify clinical margin variability during MWA treatments with the Perseon ablation 
system [9].   
 
Figure 5.3:  Simulation geometry of the MWA antenna at an air-liver boundary that 
was compared to the experimental SAR data. Note that the ablation zone is on the 
surface of the liver (not in air). 
 
Table 5.1 presents the temperature dependent dielectric and thermal properties 
used in our simulations within liver. The parameterizations of the liver permittivity 
and electrical conductivity was also employed in a prior investigation for modeling 
MWA procedures within liver at 915 MHz [9].  Moreover, a similar linear 
approximation for thermal conductivity was used, where k0 is the thermal conductivity 
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at the reference temperature, k1 is a temperature coefficient, and T and T0 are the 
transient and reference temperatures [26,27]. Determination of k0 and k1 was based on 
experimental data previously reported for experiments performed on human and 
porcine liver [28,29]. In addition, we used a temperature dependent specific heat 
capacity parameterization in our simulation. A Gaussian function centered at the 
boiling point of water is used to simulate the added heat sink associated with tissue 
water evaporation [30]. 
Table 5.1. Temperature dependent liver dielectric and thermal property 
parameterization used in models 
εr (T) σ (T) κ(T) T(°C ) 
    
                                                                  0-95 
                                                              95-100 
30 0.82                        >100 
    
 
Results 
 
The spatial profiles of SAR and temperature at several time points during the 
ablation experiment for the short-tip and long-tip Perseon applicators are illustrated in 
Figure 5.4 and Figure 5.5.  For both figures the thermal conduction correction was 
applied for SAR calculations. Figure 5.4 and figure 5.5 also illustrate simulated 
temperature and SAR spatial profiles during the course of an ablation for the short-tip 
and long-tip applicators.  Figure 5.6 is a photo of the ablation zone following a 15 W, 
6 minute ablation using the short-tip applicator and long-tip applicator. Figure 5.7 is a 
comparison ablation zone dimensions between simulation and experiment of a short-
tip applicator. The 60 ºC isothermal contour was used to compare the extent of the 
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ablation zone of simulation vs. experiment. The simulated and average experimentally 
measured transverse  and axial ablation zone diameters were 1.28 cm and 1.30 cm (+/- 
0.0327cm) and 2.10 cm and 2.66cm (+/-0.223cm) after 5 minutes of heating. 
Moreover dice coefficient comparison shows an average of 0.832 (+/-  0.025), 
demonstrating good agreement.  Figure 5.8 is a comparison of transient SAR profile 
between experiment and simulation, for a 15 W ablation with a short-tip antenna. 
Table 5.2 contains Dice coefficient comparison of the SAR profiles for the ex vivo 
ablation experiments to the simulated transient profile at various time points. 
(a) 
 
 
(b) 
 
Figure 5.4:  (a) Temperature (top) and SAR (bottom) spatial profiles during the course 
of an ablation experiment using the short-tip applicator. (b) Temperature (top) and 
SAR (bottom) spatial profiles during the course of an ablation simulation using the 
short-tip applicator. 
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(a) 
 
(b) 
Figure 5.5:  (a) Temperature (top) and SAR (bottom) spatial profiles during the course 
of an ablation experiment using the long-tip applicator. (b) Temperature (top) and 
SAR (bottom) spatial profiles during the course of an ablation simulation using the 
long-tip applicator. 
 
 
 
 
Figure 5.6:  Axial view of a 15 W 6 minute ablation on an exvivo liver sample using 
the short-tip applicator (left) and long-tip applicator (right). 
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Figure 5.7:  Comparison of simulation and experiment for a 15 W ablation (half liver-
half air) using the short-tip applicator. The 60 ºC isothermal contour was used to 
compare the extent of the ablation zone of simulation vs. experiment (n=3) at 1 minute 
(DSC agreement = 0.788 +/- 0.0655) ),  3 minutes (DSC agreement = 0.832 +/-0.0248 
) and  6 minutes ( DSC agreement = 0.845 +/- 0.0252   ). Temperature maps are shown 
from simulation. 
 
 
Figure 5.8: Comparison of simulated transient SAR profile to experimentally 
measured SAR profile during ablation 
 
Table 5.2: Dice coefficient comparison of the SAR profiles between ex vivo 
experiments and simulation at various time points. 
 
Applicator 0 sec 
DSC 
20 s 
DSC 
60 s 
DSC 
150 s 
DSC 
210 s 
DSC 
330 s 
DSC 
  
         
1000 W/kg  iso-SAR         
Short-tip 0.740+/-.045 0.738 +/-.043 0.715+/-.031 0.753+/-.032 0.759+/-.023 0.738+/-.01   
Long-tip 
0.773+/-.028 0.749+/-.060 0.748+/-.020 0.742+/-.010 0.716+/-.010 0.766+/-.033 
  
         
500 W/kg iso-SAR         
           Short-tip 0.832+/-.011 0.803+/-.026 0.760+/-.050 0.771+/-.049 0.766+/-.032 0.816-/-.043   
  Long-tip 0.769+/-.013 0.746+/-.012 0.774+/-.015 0.755+/-.013 0.768+/-.010 0.759+/-.010   
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Discussion 
 
Infrared cameras have been employed in prior studies to evaluate tissue or 
phantom heating for thermal therapy devices [21,22,23]. Here, we used infrared 
camera measurements on ex vivo liver tissue to quantify temperature and SAR of two 
clinically employed MWA antennas. By intermittently turning power off, we were 
able to correct for thermal conduction (equations 5.1, 5.2, 5.3) and thus calculate SAR 
both initially and during ablation, to characterize changes in SAR. We used the results 
of these experimental measurements to validate a prior multi-physics MWA model 
[9]. There was reasonable agreement in shape and dimension of the ablation zone 
(defined by the 60 ºC isotherm), with deviations of 0.3 cm (traverse diameter) and 0.4 
cm (axial diameter) (Figures 5.6, 5.7). There was however a considerable change in 
SAR observed during the experiments, which was not apparent in the computer 
models. For both short-tip and long-tip applicator experimental studies, hot spots were 
apparent during the first 150 seconds but disappeared later (Figures 5.4 (a), 5.5(a)). A 
similar change in SAR was not apparent in the computer simulations (Figures 5.4(b), 
5.5(b)) suggesting that the temperature dependence of tissue properties – particularly 
that of dielectric properties – is not adequately captured in the simulation. This may be 
in part due to the difficulty of direct measurement of temperature dependence of 
dielectric properties, particularly at high temperatures (> 100 ºC). While there are 
reports of temperature dependent tissue dielectric properties at 915 MHz, 
measurements at 2.45 GHz suggest values of tissue electrical conductivity and 
permittivity drop considerably at temperatures in excess of ~ 80 C [31,32], attributed 
to loss of tissue water. A similar trend at 915 MHz would suggest reductions in SAR 
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at tissue temperature in excess of 100 C , which was not observed in experiments for t 
< 50 s. Our results suggest that the greatest changes in SAR occur once tissue 
temperature exceeds 100 ºC (see Figures 4, 5, t=360 s). 
Differences were also observed in the temperature profile, with more uniform 
temperature surrounding the antenna in experimental studies, and larger gradients in 
the computer simulations –a result from the differences in SAR pattern. 
In addition, comparison of simulated SAR profile to experimentally measured 
SAR profile for a 15 W, 6 minute ablation with the short-tip applicator at different 
time points is illustrated in Figure 8. Table 5.1 shows approximately 78 % agreement 
between the simulated and experimentally measured transient SAR profiles.  The 18-
20% discrepancy between simulation and experiment depicted in Table 1 and Figure 
5.8, is in part likely because the simulated ablation captured the SAR along the shaft 
of the antenna.  
We experimentally demonstrated considerable change in SAR during ablation, 
which is not adequately captured in the computer simulation, likely due to 
inaccuracies in temperature dependence of dielectric properties. Nevertheless, the 
ablation zone dimensions between simulation and experiment agreed reasonably well 
suggesting that the impact of this change in SAR during heating is somewhat limited. 
In future work we will examine an alternate modeling approach based on using 
these experimentally measured SAR data as direct input into the simulation framework 
to simulate ablation zone extents. Such a simulation approach does not require 
knowledge of the specific antenna design, and is also computationally less demanding 
allowing shorter simulation times. While we employed infrared thermometry in this 
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study, the proposed technique to estimate SAR changes during heating may also be 
employed with magnetic resonance thermometry to facilitate 3D measurements.  
 
Conclusion 
 
The focus of this study was to experimentally characterize the transient power 
deposition pattern during MWA given a commercially available antenna with known 
geometry. The experimental results suggest significant changes in SAR during heating 
which were not present in simulation results, though ablation zone dimensions agreed 
well between model and experiment. The experimentally measured SAR data may 
potentially be used in computer simulations to predict ablation zone dimensions for 
MWA when the antenna geometry is unknown. 
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CHAPTER 6 
 
SUMMARY AND CLINICAL IMPACT 
This manuscript in  developing ablation treatment planning and guidance tools 
for accurate and precise treatment delivery.  Chapter 3 focused on presenting methods 
and results for building and validating a model for simulating MWA procedures for a 
Person Medical’s MWA applicators (a clinically used system. In summary, the 
model’s accuracy was confirmed by showing the agreement between simulated and 
measured ablation extents and radial temperature slope for 60 W and 30 W. Therefore, 
the dielectric and thermal liver tissue parameterizations used in this study may be good 
approximations for modeling the dynamic changes that occur during MWA treatments  
at 915 MHz.   
Chapter 4 presented data on investigating the variability in the physical 
parameters incorporated in MWA treatments.  While computational models afford the 
flexibility for including detailed tissue anatomy and heterogeneity, a balance between 
model complexity, accuracy, and required computational resources must be struck for 
practical clinical application. This data presented in chapter 5 may potentially provide 
guidelines for the level of detail needed for patient-specific modeling of MWA 
procedures. The results from simulating treatment effects given variance in tissue 
thermal and electrical properties will help to better approximate MWA zone extents 
using biophysical modeling techniques.  Moreover, these simulations help identify 
properties that clinicians and engineers should concentrate on in patient-specific 
modeling, and which properties we can approximate with a certain level of 
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confidence.    Ultimately, this study will help understand and effectively predict the 
underlying bio-physical changes that occur over the duration of MWA procedures in 
order to make a more useful treatment planning system. Although, more data needs to 
be collected in order to develop a clinically useful treatment planning simulation tool, 
the presented results will help in developing a potential platform for incorporating 
patient specific biophysical measurements for simulating MWA procedures.  
Chapter 5 discussed a methodology for potentially extend these simulation 
methods to other devices with unknown geometry by investigating alternative 
techniques for providing thermal spatial estimates during MWA procedure. It focused 
on  experimentally characterize the transient power deposition pattern during MWA 
using the Person MWA applicator in  with known geometry. The experimental results 
suggest significant changes in SAR during heating which were not present in 
simulation results, though ablation zone dimensions agreed well between model and 
experiment. The experimentally measured SAR data may potentially be used in 
computer simulations to predict ablation zone dimensions for MWA when the antenna 
geometry is unknown (most clinical situations). 
  
 
 
 
 
 
